Bruno Crestani

Q: What Schools Are Affiliated With Bruno Crestani

Bruno Crestani is affiliated with the following schools: University of Miyazaki, Université Paris Cité, Stanford University, Paris Diderot University

Bruno Crestani's AcademicInfluence.com Rankings

Bruno Crestani

Computer Science

#6230

World Rank

#6571

Historical Rank

Machine Learning

#1950

World Rank

#1976

Historical Rank

Artificial Intelligence

#2198

World Rank

#2236

Historical Rank

Database

#3330

World Rank

#3471

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Bruno Crestani's Degrees

PhD Computer Science Stanford University
Masters Computer Science Stanford University
Bachelors Computer Science Stanford University

Similar Degrees You Can Earn

Why Is Bruno Crestani Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Bruno Crestani's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. (2013) (2746)
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis (2016) (891)
Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis. (2010) (362)
NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFβ1-induced fibroblast differentiation into myofibroblasts (2010) (273)
Compartmentalized cytokine production within the human lung in unilateral pneumonia. (1994) (260)
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial. (2020) (241)
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease (2018) (240)
Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome. (1998) (238)
Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death. (2003) (238)
rodletless mutants of Aspergillus fumigatus (1994) (222)
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline (2022) (215)
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial (2021) (195)
Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysema (2008) (194)
Alveolar type II epithelial cells produce interleukin-6 in vitro and in vivo. Regulation by alveolar macrophage secretory products. (1994) (182)
The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis (2018) (175)
Cutting Edge: Nonproliferating Mature Immune Cells Form a Novel Type of Organized Lymphoid Structure in Idiopathic Pulmonary Fibrosis1 (2006) (174)
Bronchiolitis Obliterans Organizing Pneumonia Syndrome Primed by Radiation Therapy to the Breast (1998) (174)
Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris (2017) (170)
Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset (2007) (162)
Compartmentalized IL-8 and elastase release within the human lung in unilateral pneumonia. (1996) (160)
Clinical characteristics and prognostic factors of pulmonary MALT lymphoma (2009) (153)
Ectopic respiratory epithelial cell differentiation in bronchiolised distal airspaces in idiopathic pulmonary fibrosis (2011) (150)
Internalization of Aspergillus fumigatus conidia by epithelial and endothelial cells (1997) (145)
Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON. (2019) (144)
The MUC5B Variant Is Associated with Idiopathic Pulmonary Fibrosis but Not with Systemic Sclerosis Interstitial Lung Disease in the European Caucasian Population (2013) (142)
Three‐dimensional investigation and scoring of extracellular matrix remodeling during lung fibrosis using multiphoton microscopy (2007) (140)
Combination therapy: the future of management for idiopathic pulmonary fibrosis? (2014) (134)
Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection (2020) (131)
Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis (2015) (127)
Tracheobronchopathia Osteochondroplastica: A Study of 41 Patients (2001) (126)
Pulmonary alveolar proteinosis (2011) (125)
Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis (2017) (123)
Physiology of the lung in idiopathic pulmonary fibrosis (2018) (121)
The hedgehog system machinery controls transforming growth factor-β-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis. (2012) (120)
Nuclear factor erythroid 2-related factor 2 nuclear translocation induces myofibroblastic dedifferentiation in idiopathic pulmonary fibrosis. (2013) (120)
Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis (2016) (117)
Assessment of deep venous thrombosis in the lower limbs and pelvis: MR venography versus duplex Doppler sonography. (1996) (113)
Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosis (2017) (111)
Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosis (2015) (109)
The respiratory system in connective tissue disorders (2005) (109)
Safety and survival data in patients with idiopathic pulmonary fibrosis treated with nintedanib: pooled data from six clinical trials (2019) (107)
Severe hematologic complications after lung transplantation in patients with telomerase complex mutations. (2015) (106)
Dendritic cells accumulate in human fibrotic interstitial lung disease. (2007) (106)
High Levels of Anti-Cyclic Citrullinated Peptide Autoantibodies Are Associated with Co-occurrence of Pulmonary Diseases with Rheumatoid Arthritis (2011) (106)
Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials (2013) (104)
Presence of a mobilizable intracellular pool of hepatocyte growth factor in human polymorphonuclear neutrophils. (2002) (103)
ANCA-associated lung fibrosis: analysis of 17 patients. (2008) (102)
Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice (2008) (100)
Adding Azathioprine to Remission‐Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg‐Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors (2017) (100)
Idiopathic pulmonary fibrosis: An update (2015) (99)
Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial. (2016) (98)
Identification of periplakin as a new target for autoreactivity in idiopathic pulmonary fibrosis. (2011) (97)
Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer. (2016) (97)
Migratory bronchiolitis obliterans organizing pneumonia after unilateral radiation therapy for breast carcinoma. (1995) (97)
Inhibition of HSP27 blocks fibrosis development and EMT features by promoting Snail degradation (2013) (96)
Rituximab therapy in autoimmune pulmonary alveolar proteinosis (2009) (94)
Idiopathic Pulmonary Fibrosis: From Epithelial Injury to Biomarkers - Insights from the Bench Side (2013) (94)
Severe Pulmonary Fibrosis as the First Manifestation of Interferonopathy (TMEM173 Mutation). (2016) (93)
Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis (2015) (88)
IgG1 and IVIg induce inhibitory ITAM signaling through FcγRIII controlling inflammatory responses. (2012) (87)
Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis. (2010) (86)
Invasive mechanical ventilation in patients with fibrosing interstitial pneumonia. (2014) (82)
Somatostatin receptor scintigraphy and gallium scintigraphy in patients with sarcoidosis. (2001) (79)
Methotrexate and rheumatoid arthritis associated interstitial lung disease (2020) (79)
Dramatic effect of sirolimus on renal angiomyolipomas in a patient with tuberous sclerosis complex. (2007) (78)
Acute Respiratory Failure after Interferon-γ Therapy of End-Stage Pulmonary Fibrosis (2003) (77)
B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis. (2015) (76)
Serial computed tomography and lung function testing in pulmonary Langerhans’ cell histiocytosis (2012) (76)
Mutations in DNAJB13, Encoding an HSP40 Family Member, Cause Primary Ciliary Dyskinesia and Male Infertility. (2016) (75)
Targeting the hedgehog-glioma-associated oncogene homolog pathway inhibits bleomycin-induced lung fibrosis in mice. (2014) (75)
Secretion of α1‐antitrypsin by alveolar epithelial cells (1994) (74)
Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs) (2020) (74)
A role for dendritic cells in bleomycin-induced pulmonary fibrosis in mice? (2010) (73)
Defect of hepatocyte growth factor secretion by fibroblasts in idiopathic pulmonary fibrosis. (2003) (73)
Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines (2014) (72)
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case–cohort study (2017) (71)
Pulmonary Fibrosis in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis (2014) (69)
Neutrophil hyperactivation correlates with Alzheimer's disease progression (2018) (67)
FGF9 and FGF18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts in vitro. (2016) (67)
Optimising experimental research in respiratory diseases: an ERS statement (2018) (67)
Keratinocyte growth factor and hepatocyte growth factor in bronchoalveolar lavage fluid in acute respiratory distress syndrome patients (2000) (66)
Keratinocyte growth factor protects against elastase-induced pulmonary emphysema in mice. (2007) (66)
Bronchiolitis obliterans organizing pneumonia syndrome primed by radiation therapy to the breast. The Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERM"O"P) (1998) (66)
Resequencing Study Confirms Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis. (2019) (66)
Is high-resolution computed tomography a reliable tool to predict the histopathological activity of pulmonary Langerhans cell histiocytosis? (2000) (64)
Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitis. (2002) (63)
Pulmonary manifestations in adult patients with chronic granulomatous disease (2015) (60)
Defect of pro-hepatocyte growth factor activation by fibroblasts in idiopathic pulmonary fibrosis. (2006) (59)
Clinical Outcome After a Totally Implantable Venous Access Port-Related Infection in Cancer Patients: A Prospective Study and Review of the Literature (2012) (59)
Intravenous Immunoglobulin as an Immunomodulating Agent in Antineutrophil Cytoplasmic Antibody–Associated Vasculitides: A French Nationwide Study of Ninety‐Two Patients (2015) (59)
Patients with IPF and lung cancer: diagnosis and management. (2017) (58)
Activation of somatostatin receptors attenuates pulmonary fibrosis (2007) (58)
Increased uptake of 111In-octreotide in idiopathic pulmonary fibrosis. (2006) (58)
Obstructive sleep apnoea and related comorbidities in incident idiopathic pulmonary fibrosis (2017) (57)
Signalling pathways from NADPH oxidase-4 to idiopathic pulmonary fibrosis. (2011) (57)
High frequency of a deletion polymorphism of the angiotensin-converting enzyme gene in asthma. (1997) (56)
Bronchopulmonary dysplasia and emphysema: in search of common therapeutic targets. (2009) (56)
Hepatocyte growth factor and lung fibrosis. (2012) (55)
The small heat‐shock protein αB‐crystallin is essential for the nuclear localization of Smad4: impact on pulmonary fibrosis (2014) (54)
Imbalance of circulating endothelial cells and progenitors in idiopathic pulmonary fibrosis (2012) (52)
Long-term treatment of patients with idiopathic pulmonary fibrosis with nintedanib: results from the TOMORROW trial and its open-label extension (2017) (52)
Prevalence of respiratory viruses among adults, by season, age, respiratory tract region and type of medical unit in Paris, France, from 2011 to 2016 (2017) (50)
[French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis. From the National Reference and the Competence centers for rare diseases and the Société de Pneumologie de Langue Française]. (2013) (50)
Management of suspected monogenic lung fibrosis in a specialised centre (2017) (50)
Defect of hepatocyte growth factor production by fibroblasts in human pulmonary emphysema. (2005) (50)
The impaired proteases and anti-proteases balance in Idiopathic Pulmonary Fibrosis. (2018) (49)
Swallowing disorders, pneumonia and respiratory tract infectious disease in the elderly. (2011) (49)
SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772) (2018) (48)
Relation between inflammation and symptoms in asthma (2009) (48)
Pulmonary phenotypes associated with genetic variation in telomere-related genes (2018) (48)
Effects of Halothane on Surfactant Biosynthesis by Rat Alveolar Type II Cells in Primary Culture (1994) (47)
[18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis (2017) (46)
Interleukin 6 secretion by monocytes and alveolar macrophages in systemic sclerosis with lung involvement. (1994) (46)
Regulation of hepatocyte growth factor secretion by fibroblasts in patients with acute lung injury. (2008) (45)
Alveolar fibroblasts in acute lung injury: biological behaviour and clinical relevance (2009) (45)
Heterogeneity of lung disease associated with NK2 homeobox 1 mutations. (2017) (44)
Treatment of cardiac sarcoidosis: A comparative study of steroids and steroids plus immunosuppressive drugs. (2019) (44)
Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials (2018) (44)
Antifibrotic role of vascular endothelial growth factor in pulmonary fibrosis (2017) (44)
Characteristics of Patients with Respiratory Allergy in France and Factors Influencing Immunotherapy Prescription: A Prospective Observational Study (Realis) (2011) (42)
Membrane-anchored Serine Protease Matriptase Is a Trigger of Pulmonary Fibrogenesis. (2016) (42)
Arterial Thrombotic Events in Adult Inpatients With COVID-19 (2020) (42)
Alveolar fibrocyte percentage is an independent predictor of poor outcome in patients with acute lung injury* (2012) (41)
Familial pulmonary fibrosis. (2015) (41)
Inducible expression and regulation of the alpha 1-acid glycoprotein gene by alveolar macrophages: prostaglandin E2 and cyclic AMP act as new positive stimuli. (1999) (41)
Severe chronic bronchiolitis as the presenting feature of primary Sjögren's syndrome. (2011) (40)
Monoclonal Anti-TNF-α Antibodies for Severe Steroid-Dependent Asthma: A Case Series (2013) (40)
French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2017 update. Full-length version. (2022) (39)
Steroid-responsive pulmonary hypertension in a patient with Langerhans' cell granulomatosis (histiocytosis X). (1996) (39)
Endothelin-1 secretion by alveolar macrophages in systemic sclerosis. (1997) (39)
Sirolimus treatment for pulmonary lymphangioleiomyomatosis. (2007) (38)
Silver nanoparticle-adjuvanted vaccine protects against lethal influenza infection through inducing BALT and IgA-mediated mucosal immunity. (2019) (38)
Diagnostic Likelihood Thresholds that Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis. (2019) (38)
Regulator of telomere length 1 (RTEL1) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypes (2019) (37)
Interleukin-8 and neutrophils in systemic sclerosis with lung involvement. (1994) (37)
Organising pneumonia can be the inaugural manifestation in connective tissue diseases, including Sjögren's syndrome (2010) (37)
Detection of Alveolar Fibrocytes in Idiopathic Pulmonary Fibrosis and Systemic Sclerosis (2013) (36)
Differential Role of Neutrophils and Alveolar Macrophages in Hepatocyte Growth Factor Production in Pulmonary Fibrosis (2002) (36)
Keratinocyte growth factor expression by fibroblasts in pulmonary fibrosis : Poor response to interleukin-1β (2005) (35)
Decreased expression of interleukin 13 in human lung emphysema (2004) (35)
European Respiratory Society statement on long COVID follow-up (2022) (35)
Morphologic and molecular study of lung cancers associated with idiopathic pulmonary fibrosis and other pulmonary fibroses (2017) (35)
Inducible expression of the alpha1-acid glycoprotein by rat and human type II alveolar epithelial cells. (1998) (34)
Critical Evaluation of Sinonasal Disease in 64 Adults with Primary Ciliary Dyskinesia (2019) (34)
Defect of alveolar regeneration in pulmonary emphysema: Role of lung fibroblasts (2007) (34)
Usual interstitial pneumonia in ANCA-associated vasculitis: A poor prognostic factor. (2019) (34)
The genetics of interstitial lung diseases (2019) (32)
Clinical and economic burden of severe asthma: A French cohort study. (2018) (32)
The Long Non-Coding RNA DNM3OS is a Reservoir of FibromiRs with Major Functions in Lung Fibroblast Response to TGF-β and Pulmonary Fibrosis. (2019) (32)
Forkhead Box F1 represses cell growth and inhibits COL1 and ARPC2 expression in lung fibroblasts in vitro. (2014) (32)
Pharmacological management of IPF (2016) (32)
Quantitative analysis of ciliary beating in primary ciliary dyskinesia: a pilot study (2012) (31)
Troubles de la déglutition du sujet âgé et pneumopathies en 14 questions/réponses (2009) (31)
Safety and efficacy of pirfenidone in patients carrying telomerase complex mutation (2018) (31)
Human airway trypsin-like protease, a serine protease involved in respiratory diseases. (2017) (30)
Clonality and phenotyping analysis of alveolar lymphocytes is suggestive of pulmonary MALT lymphoma. (2011) (30)
TRIM33 prevents pulmonary fibrosis by impairing TGF-β1 signalling (2020) (30)
Psychometric properties and minimal important differences of SF-36 in Idiopathic Pulmonary Fibrosis (2019) (30)
A systematically derived exposure assessment instrument for Chronic Hypersensitivity Pneumonitis. (2020) (29)
Hepatocyte growth factor is produced by blood and alveolar neutrophils in acute respiratory failure. (2002) (29)
Effect of anti-acid medication on reduction in FVC decline with nintedanib (2015) (28)
Combined pulmonary fibrosis and emphysema in systemic sclerosis: A syndrome associated with heavy morbidity and mortality. (2019) (28)
Analysis of body mass index, weight loss and progression of idiopathic pulmonary fibrosis (2020) (28)
Rituximab for auto-immune alveolar proteinosis, a real life cohort study (2018) (28)
111In-pentetreotide scintigraphy in patients with Langerhans' cell histiocytosis. (2000) (27)
Management of idiopathic pulmonary fibrosis in France: a survey of 1244 pulmonologists. (2012) (27)
Pulmonary tuberculosis: computed tomography and high-resolution computed tomography patterns in patients who are either HIV-negative or HIV-seropositive. (1998) (26)
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial. (2021) (26)
Investigation of Lung Involvement in Connective Tissue Disorders (2015) (26)
Lung CT Densitometry in Idiopathic Pulmonary Fibrosis for the Prediction of Natural Course, Severity, and Mortality (2019) (26)
NHP2 deficiency impairs rRNA biogenesis and causes pulmonary fibrosis and Høyeraal-Hreidarsson syndrome. (2020) (26)
Idiopathic interstitial lung disease with anti-SSA antibody. (2011) (25)
Control and exacerbation of asthma: a survey of more than 3000 French physicians (2004) (25)
Hepatocyte and keratinocyte growth factors and their receptors in human lung emphysema (2005) (25)
Acute respiratory failure after interferon-gamma therapy of end-stage pulmonary fibrosis. (2003) (25)
Pharmacological Targeting of Protease-Activated Receptor 2 Affords Protection from Bleomycin-Induced Pulmonary Fibrosis (2015) (25)
Differential effects of halothane and thiopental on surfactant protein C messenger RNA in vivo and in vitro in rats. (2000) (24)
Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial (2021) (24)
Transcriptome of Cultured Lung Fibroblasts in Idiopathic Pulmonary Fibrosis: Meta-Analysis of Publically Available Microarray Datasets Reveals Repression of Inflammation and Immunity Pathways (2016) (23)
High mass (>18g) of late gadolinium enhancement on CMR imaging is associated with major cardiac events on long-term outcome in patients with biopsy-proven extracardiac sarcoidosis. (2016) (23)
Successful rapid tocilizumab desensitization in a patient with Still disease. (2014) (22)
Antineutrophil Cytoplasmic Antibody–Associated Lung Fibrosis (2018) (22)
Familial vs. sporadic sarcoidosis: BTNL2 polymorphisms, clinical presentations, and outcomes in a French cohort (2016) (22)
Orbital mass in ANCA-associated vasculitides: data on clinical, biological, radiological and histological presentation, therapeutic management, and outcome from 59 patients. (2019) (22)
Increased expression of protease nexin-1 in fibroblasts during idiopathic pulmonary fibrosis regulates thrombin activity and fibronectin expression (2014) (22)
Familial forms of nonspecific interstitial pneumonia/idiopathic pulmonary fibrosis: clinical course and genetic background (2012) (22)
Dysregulation of elastin expression by fibroblasts in pulmonary emphysema: role of cellular retinoic acid binding protein 2 (2008) (22)
Antifibrotic role of αB-crystallin inhibition in pleural and subpleural fibrosis. (2014) (22)
Interleukin-8 release by endothelial colony-forming cells isolated from idiopathic pulmonary fibrosis patients might contribute to their pathogenicity (2019) (21)
Efficacy and safety of rituximab in patients with chronic hypersensitivity pneumonitis (cHP): A retrospective, multicentric, observational study. (2020) (21)
Pilot experience of multidisciplinary team discussion dedicated to inherited pulmonary fibrosis (2019) (21)
Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts (2017) (21)
Safety and efficacy of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis and carrying a telomere-related gene mutation (2020) (21)
Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis (2015) (21)
Is personalised medicine the key to heterogeneity in idiopathic pulmonary fibrosis? (2017) (20)
Non-influenza respiratory viruses in adult patients admitted with influenza-like illness: a 3-year prospective multicenter study (2020) (20)
Manifestations respiratoires au cours du syndrome de Gougerot-Sjögren (2007) (20)
Role of nitric oxide synthases in elastase-induced emphysema (2011) (20)
HGF synthesis in human lung fibroblasts is regulated by oncostatin M. (2006) (20)
[French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis: 2017 update. Summary]. (2017) (20)
French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2017 update. Short-length version. (2017) (19)
Lung ultrasonography in patients with COVID-19: comparison with CT (2020) (19)
Chaotic activation of developmental signalling pathways drives idiopathic pulmonary fibrosis (2020) (19)
French recommendations for the management of systemic sclerosis (2021) (19)
Tracheobronchial amyloidosis with hilar lymphadenopathy associated with a serum monoclonal immunoglobulin. (1993) (19)
BARD1 mediates TGF-β signaling in pulmonary fibrosis (2015) (18)
Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study (2012) (18)
Outcomes following decline in forced vital capacity in patients with idiopathic pulmonary fibrosis: Results from the INPULSIS and INPULSIS-ON trials of nintedanib. (2019) (18)
Macrophage Polarization Favors Epithelial Repair During Acute Respiratory Distress Syndrome* (2018) (18)
NADPH oxidase DUOX1 sustains TGF-β1 signalling and promotes lung fibrosis (2020) (18)
ETB receptor polymorphism is associated with airway obstruction (2007) (17)
Treatments for idiopathic pulmonary fibrosis. (2014) (17)
Long‐term treatment with nintedanib in Asian patients with idiopathic pulmonary fibrosis: Results from INPULSIS®‐ON (2019) (17)
Neutrophil DNA contributes to the antielastase barrier during acute lung inflammation. (2003) (17)
Long-term treatment with nintedanib in patients with IPF: an update from INPULSIS-ON (2016) (17)
Chlorambucil-associated pneumonitis. (1994) (17)
Benefits and Risks of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (2002) (17)
Current management of lymphangioleiomyomatosis (2011) (17)
The MUC5B promoter risk allele for idiopathic pulmonary fibrosis predisposes to asbestosis (2020) (16)
Licence to kill senescent cells in idiopathic pulmonary fibrosis? (2017) (16)
Inflammatory role of alveolar epithelial cells. (1998) (16)
Prevalence of telomere shortening in familial and sporadic pulmonary fibrosis is increased in men. (2009) (16)
Giant hiatal hernia: beware of the supine ICU chest X-ray! (2017) (16)
Keratinocyte growth factor expression by fibroblasts in pulmonary fibrosis: poor response to interleukin-1beta. (2005) (16)
Cystic lung disease in Sjögren's syndrome: An observational study. (2017) (16)
Cell surface carbohydrates modulate neutrophil adherence to alveolar type II cells in vitro. (1993) (15)
Challenges in IPF diagnosis, current management and future perspectives. (2015) (15)
A 2-Year Observational Study in Patients Suffering from Idiopathic Pulmonary Fibrosis and Treated with Pirfenidone: A French Ancillary Study of PASSPORT (2019) (15)
Imbalance in the pro-hepatocyte growth factor activation system in bleomycin-induced lung fibrosis in mice. (2010) (15)
Guide pour le suivi respiratoire des patients ayant présenté une pneumonie à SARS-CoV-2. Propositions de prise en charge élaborées par la Société de pneumologie de langue française. Version du 10 mai 2020 (2020) (15)
Observer agreement and clinical significance of chest CT reporting in patients suspected of COVID-19 (2020) (15)
Airway-Centered Fibroelastosis: A Distinct Entity. (2016) (15)
Anti-SSA Ro52/Ro60 antibody testing by immunodot could help the diagnosis of Sjogren's syndrome in the absence of anti-SSA/SSB antibodies by ELISA. (2013) (15)
Distinguishing the histological and radiological features of cystic lung disease in Birt–Hogg–Dubé syndrome from those of tobacco‐related spontaneous pneumothorax (2014) (15)
The pro-apoptotic BAX protein influences cell growth and differentiation from the nucleus in healthy interphasic cells (2017) (15)
Recent advances in rheumatoid arthritis-associated interstitial lung disease. (2020) (14)
P7 Interim analysis of nintedanib in an open-label extension of the INPULSIS® trials (INPULSIS®-ON) (2015) (14)
FGF9 prevents pleural fibrosis induced by intrapleural adenovirus injection in mice. (2017) (14)
Different lansoprazole (LA) dosages in H. pylori (Hp) eradication therapy: A prospective multicenter randomized study comparing 30 MG B.I.D. vs. 15 MG B.I.D. (1998) (14)
Keratinocyte growth factor et Hepatocyte growth factor: rôles dans la réparation épithéliale alvéolaire. (2003) (14)
Adherence to guidelines in idiopathic pulmonary fibrosis: a follow-up national survey (2015) (14)
Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP) (2019) (14)
Differential effects of isoflurane and i.v. anaesthetic agents on metabolism of alveolar type II cells. (1999) (14)
Increased Uptake of 111 In-Octreotide in Idiopathic Pulmonary Fibrosis (2006) (13)
Asthma unmasked with tumor necrosis factor-α-blocking drugs. (2011) (13)
Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study (2020) (13)
Recommandations pratiques pour le diagnostic et la prise en charge de la fibrose pulmonaire idiopathique – Actualisation 2021. Version courte (2017) (13)
Bi-allelic missense ABCA3 mutations in a patient with childhood ILD who reached adulthood (2019) (13)
Toll-like receptor 4 activation attenuates profibrotic response in control lung fibroblasts but not in fibroblasts from patients with IPF. (2017) (13)
Guide de prise en charge des séquelles respiratoires post infection à SARS-CoV-2. Propositions de prise en charge élaborées par la Société de Pneumologie de Langue Française. Version du 10 novembre 2020 (2020) (13)
[Guide for follow-up of patients with SARS-CoV-2 pneumonia. Management proposals developed by the French-language Respiratory Medicine Society. Version of 10 May 2020]. (2020) (13)
Functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer (2020) (13)
Identification of periplakin as a major regulator of lung injury and repair in mice. (2018) (13)
Clinical and Functional Characteristics of Patients with Unclassifiable Interstitial Lung Disease (uILD): Long-Term Follow-Up Data from European IPF Registry (eurIPFreg) (2020) (12)
Évaluation de la fonction respiratoire chez le sujet âgé: Intergroupe Pneumo Gériatrie SPLF-SFGG1 (2006) (12)
Manifestations respiratoires du syndrome de Marfan. (2015) (12)
MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression. (2021) (12)
Alveolar fluid in acute respiratory distress syndrome promotes fibroblast migration: Role of platelet-derived growth factor pathway* (2012) (12)
Increased volume of conducting airways in idiopathic pulmonary fibrosis is independent of disease severity: a volumetric capnography study (2016) (11)
Rapid improvement of symptomatology with pantoprazole, amoxycillin and metronidazole in Helicobacter pylori-positive duodenal ulcer patients. (1999) (11)
Basophils and IgE contribute to Mixed Connective Tissue Disease development. (2020) (11)
Parathyroid hormone-related protein in epithelial lining fluid in humans negatively correlates with the severity of lung injury. (2002) (11)
Lung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patients (2020) (11)
Pneumocystosis revealing immunodeficiency secondary to TERC mutation (2017) (11)
CA 50 Determination in body fluids: Can we screen patients at risk for gastric cancer? (1991) (11)
The risk/benefit of inhaled corticosteroids in chronic obstructive pulmonary disease (2005) (10)
Assessing the Effectiveness of Pirfenidone in Idiopathic Pulmonary Fibrosis: Long-Term, Real-World Data from European IPF Registry (eurIPFreg) (2020) (10)
Germline SFTPA 1 mutation in familial idiopathic interstitial pneumonia and lung cancer (2016) (10)
First heterozygous NOP10 mutation in familial pulmonary fibrosis (2020) (10)
Human lung fibroblasts may modulate dendritic cell phenotype and function: results from a pilot in vitro study (2016) (10)
Is chronic exposure to air pollutants a risk factor for the development of idiopathic pulmonary fibrosis? (2018) (10)
[Keratinocyte growth factor and Hepatocyte growth factor: their roles in alveolar epithelial repair]. (2003) (10)
Tracheobronchial amyloidosis: evidence for local B-cell clonal expansion (2012) (10)
Interstitial lung disease due to polymyositis or dermatomyositis: effect of a 6-month course of i.v. pulse cyclophosphamide. (2005) (10)
Missing data in IPF trials: do not let methodological issues undermine a major therapeutic breakthrough (2015) (10)
[Respiratory manifestations of Marfan's syndrome]. (2015) (9)
Eight novel variants in the SLC34A2 gene in pulmonary alveolar microlithiasis (2019) (9)
Fulminant Acute Respiratory Distress Syndrome After Calcineurin Inhibitor-belatacept Conversion in a Lung Transplant Recipient. (2018) (9)
Fibroblasts: the missing link between fibrotic lung diseases of different etiologies? (2013) (9)
Granulomatous foreign‐body reaction with facial dermal fillers after omalizumab treatment for severe persistent allergic asthma: a case report (2012) (9)
Post hoc Analysis of Clinical Outcomes in Placebo- and Pirfenidone-Treated Patients with IPF Stratified by BMI and Weight Loss (2021) (9)
Long-term nintedanib treatment in idiopathic pulmonary fibrosis (IPF): new data from INPULSIS-ON (2017) (9)
Sonic Hedgehog signaling in pulmonary fibrosis: a spiky issue? (2013) (9)
The Genetic Diagnosis of Interstitial Lung Disease: A Need for an International Consensus. (2017) (9)
A Risk Score to Detect Subclinical Rheumatoid Arthritis–Associated Interstitial Lung Disease (2022) (9)
Immune checkpoint blockade for patients with lung cancer and idiopathic pulmonary fibrosis. (2021) (9)
Interstitial lung disease in lysosomal storage disorders (2021) (9)
[Evaluation of pulmonary function in the elderly. Intergroupe Pneumo Gériatrie SPLF-SFGG]. (2006) (9)
International registry for idiopathic pulmonary fibrosis. (2008) (8)
18F-FDG PET/CT in bone sarcoidosis: an observational study (2020) (8)
Perip7lakin is a target for autoimmunity in asthma (2016) (8)
Lipoprotéinose alvéolaire pulmonaire (2011) (8)
Retour d’expérience sur la direction médicale de crise à l’Assistance publique–Hôpitaux de Paris pendant la crise Covid-19 (2020) (8)
Hypoxia reduces endothelin production by rat alveolar type II cells in primary culture. (1998) (8)
FGF19 is Downregulated in Idiopathic Pulmonary Fibrosis and Inhibits Lung Fibrosis in Mice. (2022) (7)
[Guide for management of patients with possible respiratory sequelae after a SARS-CoV-2 pneumonia. Support proposals developed by the French-speaking Respiratory Medicine Society. Version of 10 November 2020]. (2020) (7)
The Ariane-IPF ERS Clinical Research Collaboration: seeking collaboration through launch of a federation of European registries on idiopathic pulmonary fibrosis (2019) (7)
[Swallowing disorders, pneumonia and respiratory tract infectious disease in the elderly]. (2009) (7)
Follow-Up and Management of Chronic Rhinosinusitis in Adults with Primary Ciliary Dyskinesia: Review and Experience of Our Reference Centers (2019) (7)
Healthcare pathway and patients' expectations in pulmonary fibrosis (2017) (7)
Comparative impact of standard approach, FDG PET and FDG dual-head coincidence gamma camera imaging in preoperative staging of patients with non-small-cell lung cancer (2003) (7)
Biology and pathology of fibroproliferation following the acute respiratory distress syndrome (2014) (7)
Bronchoalveolar lavage brings mesenchymal stem cells to the light. (2012) (7)
[Diesel particles and allergy: cellular mechanisms]. (2000) (7)
Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous disease (2009) (7)
Cytokeratin 19 fragments in patients with acute lung injury: a preliminary observation (2006) (6)
Cancer bronchique du sujet âgé (2007) (6)
A 70-year-old woman with acute chest pain and a paracardiac mass. (2013) (6)
Mécanismes de la fibrogenèse pulmonaire. (2007) (6)
Traitements médicamenteux de la fibrose pulmonaire idiopathique (2005) (6)
Determinants of survival after lung transplantation in telomerase‐related gene mutation carriers: A retrospective cohort (2021) (6)
French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis: 2017 update. Summary. (2017) (6)
Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part one (2017) (6)
Mesenchyme associated transcription factor PRRX1: A key regulator of IPF fibroblast (2016) (6)
[Crohn's disease and leukemia]. (1989) (6)
Calcium-solubilizing sodium thiosulfate failed to improve pulmonary alveolar microlithiasis: Evaluation of calcium content with CT scan. (2019) (6)
Maladie de Niemann-Pick de type B révélée par une atteinte bronchopulmonaire (2008) (6)
Impact of genetic factors on fibrosing interstitial lung diseases. Incidence and clinical presentation in adults (2020) (6)
A case of obstructive sleep apnea syndrome: unusual comorbidity (2008) (6)
Lung infiltrate in a male with a bronchopleural fistula (2003) (6)
[A operational plan on behalf of chronic obstructive bronchopneumopathy. 2005-2010. Knowledge, prevention and improved management of COBP]. (2006) (6)
[French practical guidelines for the diagnosis and management of IPF - 2021 update, short version]. (2022) (5)
Evaluation of efficacy and safety of rituximab in combination with mycophenolate mofetil in patients with nonspecific interstitial pneumonia non-responding to a first-line immunosuppressive treatment (EVER-ILD): A double-blind placebo-controlled randomized trial. (2020) (5)
Voies aériennes distales et maladies de système (2012) (5)
A French National Prospective Cohort of Patients with Idiopathic Pulmonary Fibrosis (IPF): Demographic Characteristics. (2009) (5)
Genetic testing in interstitial lung disease: An international survey (2022) (5)
Serum Amyloid P Contained in Alveolar Fluid From Patients With Acute Respiratory Distress Syndrome Mediates the Inhibition of Monocyte Differentiation into Fibrocyte (2016) (5)
Gender Differences in Idiopathic Pulmonary Fibrosis: Are Men and Women Equal? (2020) (5)
Dysregulated balance of lung macrophage populations in idiopathic pulmonary fibrosis revealed by single-cell RNA seq: an unstable “ménage-à-trois” (2019) (5)
Anti-parietal cell autoimmunity is associated with an accelerated decline of lung function in IPF patients. (2018) (5)
AB0007 Shared genetic predisposition in rheumatoid arthritis–interstitial lung disease and familial pulmonary fibrosis (2017) (5)
Talc pleurodesis allows long-term remission in HIV-unrelated Human Herpesvirus 8-associated primary effusion lymphoma (2017) (5)
Low income and outcome in idiopathic pulmonary fibrosis: An association to uncover. (2021) (5)
Pneumopathie organisée au sirolimus : un diagnostic à évoquer chez le patient transplanté d'organe (2006) (5)
Interstitial lung diseases associated with mutations of poly(A)‐specific ribonuclease: A multicentre retrospective study (2022) (5)
Towards a global initiative for fibrosis treatment (GIFT) (2017) (5)
Isoniazid-monoresistant tuberculosis in France: risk factors, treatment outcomes and adverse events. (2021) (5)
Blood fibrocytes are associated with severity and prognosis in COVID-19 pneumonia (2021) (5)
[Respiratory manifestations during the course of Sjogren's syndrome]. (2007) (5)
Accuracy Of A Clinical Diagnosis Of Idiopathic Pulmonary Fibrosis: A Study Of 275 Pulmonologists From 54 Countries (2017) (5)
[From fibrogenesis towards fibrosis: Pathophysiological mechanisms and clinical presentations]. (2020) (4)
Lung Fibroblasts from Idiopathic Pulmonary Fibrosis Patients Harbor Short and Unstable Telomeres Leading to Chromosomal Instability (2022) (4)
Les atteintes respiratoires au cours du syndrome de Gougerot-Sjögren (2006) (4)
Translational Research in Acute Lung Injury and Pulmonary Fibrosis Forkhead Box F 1 represses cell growth and inhibits COL 1 and ARPC 2 expression in lung fibroblasts in vitro (2014) (4)
[Pneumopathy caused by minocycline]. (1997) (4)
Iconography : Pneumopathie organisée (2010) (4)
Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants. (2023) (4)
CCAAT/enhancer binding protein delta (C/EBPδ) deficiency does not affect bleomycin-induced pulmonary fibrosis (2018) (4)
Inducible Expression of the α1-Acid Glycoprotein by Rat and Human Type II Alveolar Epithelial Cells (1998) (4)
Safety and efficacy of pirfenidone in patients with lung fibrosis and TERT mutation (2016) (4)
[French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis. 2017 update. Full-length update]. (2017) (4)
Manifestations pleuro-pulmonaires au cours de la polyarthrite rhumatoïde (1996) (4)
Safe and effective use of nivolumab for treating lung adenocarcinoma associated with sporadic lymphangioleiomyomatosis: a rare case report (2019) (4)
Changes in biomarkers in patients with idiopathic pulmonary fibrosis (IPF) treated with nintedanib and sildenafil (2019) (4)
NKX2.1 (TTF1) germline mutation associated with pulmonary fibrosis and lung cancer (2021) (4)
J2R, première édition ! (2005) (4)
Familial pulmonary fibrosis: a world without frontiers (2019) (4)
The use of exhaled air analysis in discriminating interstitial lung diseases: a pilot study (2022) (4)
Clinical and molecular characteristics of unicentric mediastinal Castleman disease. (2018) (4)
European Respiratory Society statement on familial pulmonary fibrosis (2022) (4)
No evidence for a pathogen associated with pulmonary MALT lymphoma: a metagenomics investigation (2020) (4)
Myelodysplastic syndromes and idiopathic pulmonary fibrosis: a dangerous liaison (2019) (4)
IL-1 beta inhibits ET-1 production by ATII cells in vitro: evidence for involvement of cyclooxygenase 2 pathway. (1997) (4)
Evaluation Of The Course Of Adult Pulmonary Langerhans Cell Histiocytosis By Serial Lung Function Tests (2011) (4)
[French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis: 2017 update. Short-length version]. (2017) (4)
Multidisciplinary team dedicated to suspected heritable pulmonary fibrosis (2018) (4)
New targets in idiopathic pulmonary fibrosis: from inflammation and immunity to remodeling and repair (2016) (4)
Pneumopathies interstitielles diffuses (2004) (3)
Treatment of Idiopathic Pulmonary Fibrosis with Capsule or Tablet Formulations of Pirfenidone in the Real-Life French RaDiCo-ILD Cohort (2021) (3)
Serotonin: a new start for an old friend? (2010) (3)
Treatment of Idiopathic Pulmonary Fibrosis with Capsule or Tablet Formulations of Pirfenidone in the Real-Life French RaDiCo-ILD Cohort (2021) (3)
Retrosternal and pleural “bridging” fibrosis mimicking malignancy in a patient exposed to asbestos (2010) (3)
[Mechanisms in pulmonary fibrosis]. (2007) (3)
Réduction de volume pulmonaire endoscopique dans l’emphysème (2018) (3)
Relation entre inflammation et symptômes dans l’asthme (2008) (3)
[The distal airways in systemic disease]. (2012) (3)
Cell surface carbohydrates of rat alveolar type II cells in primary culture. (1993) (3)
M33 Long-term efficacy of nintedanib is maintained in patients with idiopathic pulmonary fibrosis (ipf) irrespective of dose: subgroup analysis of inpulsis-on (2017) (3)
OP0053 Eular/ERA-EDTA Recommendations for The Management of Anca-Associated Vasculitis (2016) (3)
Effect of nintedanib on progression of systemic sclerosis-associated interstitial lung disease (SSc-ILD) beyond 52 weeks: data from the SENSCIS trial (2020) (3)
A first step against idiopathic pulmonary fibrosis (2011) (3)
Detection of anti-periplakin auto-antibodies during idiopathic pulmonary fibrosis. (2014) (3)
Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan (2013) (3)
Genetic testing in idiopathic interstitial pneumonia (2015) (3)
Severe asthma with blood hypereosinophilia associated with JAK2 V617F mutation: a case series (2019) (3)
Genotype-Phenotype Relationships in Inheritable Idiopathic Pulmonary Fibrosis: A Greek National Cohort Study (2022) (3)
Nécrose de la graisse médiastinale (2015) (3)
P11 Bronchiolite oblitérante avec pneumopathie en voie d'organisation (BOOP) compliquant une radiothérapie mammaire: 15 observations (1998) (2)
Pioglitazone in pulmonary alveolar proteinosis: promising first clinical experience. (2020) (2)
European IPF Patient Charter: an SOS to the world (2016) (2)
Pneumothoraces in Birt–Hogg–Dubé syndrome compared to smoking related blebs (2014) (2)
[Treatment of alveolar proteinosis by intrapulmonary transplantation of macrophages]. (2015) (2)
No association between human herpesvirus or herpesvirus saimiri and idiopathic pulmonary fibrosis (2020) (2)
Diagnostic value of serum VEGF-D in consecutive patients with lymphangioleiomyomatosis (2011) (2)
Diagnostic des pneumopathies infiltrantes diffuses chroniques (2004) (2)
Actualités dans les pneumopathies interstitielles idiopathiques en 2016 (2017) (2)
Emphysème pulmonaire : évolution des concepts (1999) (2)
Interstitial Lung Disease in Connective Tissue Diseases Other Than Systemic Sclerosis (2015) (2)
État des lieux de la BPCO en France en 2005 (2006) (2)
COVID-19 Acute Respiratory Distress Syndrome promotes a specific alternative macrophage polarization (2022) (2)
Identification of Paired-related Homeobox Protein 1 as a key mesenchymal transcription factor in Idiopathic Pulmonary Fibrosis (2021) (2)
Pathologie tumorale médiastinale : démarche diagnostique et thérapeutique (2006) (2)
M29 Fvc decline over 1 year predicts mortality but not subsequent fvc decline in patients with ipf (2017) (2)
POS0062 A RISK SCORE TO DETECT SUBCLINICAL RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (2022) (2)
Fibrose pulmonaire idiopathique (2009) (2)
[French recommendations for idiopathic pulmonary fibrosis: Oriented toward practice]. (2013) (2)
HGF and lung carcinoma: Don't forget neutrophils. (2006) (2)
Differentiation Of Human Blood Monocyte Subsets Into Fibrocytes Is Inhibited By Alveolar Environment During Acute Lung Injury (2012) (2)
[Niemann-Pick disease type B identified following an episode of bronchopneumonia]. (2008) (2)
Evaluation of the safety, tolerability, pharmacokinetics and pharmacodynamics of ascending repeated doses of SAR156597 in patients with Idiopathic Pulmonary Fibrosis (IPF): a randomized, double‐blind, placebo‐controlled study. (2014) (2)
Pneumopathies interstitielles diffuses idiopathiques (2004) (2)
[Mediastinal fat necrosis]. (2015) (2)
Thoracic involvement of diffuse lymphangiomatosis successfully treated with sildenafil (2019) (2)
[Respiratory symptoms in the Gougerot-Sjogren syndrome]. (2006) (2)
Diagnosis yield and safety of surgical biopsy in interstitial lung diseases: a prospective study. (2021) (2)
Tolerance and efficacy of antifibrotic treatments in IPF patients carriying telomere related gene mutations (2019) (2)
[Respiratory manifestations during the course of Sjogren's syndrome]. (2010) (2)
Patterns of discontinuation in patients with IPF treated with open-label nintedanib: data from INPULSIS-ON (2018) (2)
[Sirolimus-associated interstitial pneumonitis in a renal transplant patient]. (2006) (2)
LAM is another small airway disease: lessons from microCT (2020) (2)
Endothelin could participate in the epithelial-mesenchymal transition of alveolar type II cells (AEC) in vitro. (2007) (2)
Pulmonary involvement in Sjögren’s syndrome (2009) (2)
COVID-19 in patients with pulmonary alveolar proteinosis: a European multicentre study (2022) (2)
Prevalence and incidence of interstitial lung diseases (ILDs) in a French multi-ethnic county (2013) (2)
Human airway trypsin‐like protease exerts potent, antifibrotic action in pulmonary fibrosis (2017) (2)
Modulation of fibroblast phenotype in idiopathic pulmonary fibrosis: Role of Nrf2 (2011) (2)
Resequencing Study Con ﬁ rms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis (2019) (2)
Une recherche pneumologique à l'INSERM: pour encore combien de temps ? (2003) (2)
Contribution Of Mutations In Genes Encoding Proteins Of The Surfactant Metabolism To Idiopathic Interstitial Pneumonia And Idiopathic Pulmonary Fibrosis In A Cohort Of 265 Families (2016) (2)
N-acetylcysteine for idiopathic pulmonary fibrosis: the door is still open-Authors' reply. (2017) (2)
Contribution of mutations in genes of the surfactant system to idiopathic interstitial pneumonia (IIP) (2018) (2)
Rheumatological evaluation of patients with interstitial lung disease. (2021) (2)
[French practical guidelines for the diagnosis and management of IPF - 2021 update, full version]. (2022) (2)
Recent advances in the management of systemic sclerosis-associated interstitial lung disease (2022) (2)
Gastro-oesophageal reflux and idiopathic pulmonary fibrosis: in search of evidence (2016) (2)
Preliminary results of the French national prospective cohort on IPF (2011) (2)
Effect of Nintedanib on Progression of Systemic Sclerosis‐Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled Trial (2022) (2)
Characteristics Of Patients With Severe Uncontrolled Allergic Asthma Who Failed To Improve After Omalizumab Therapy (2011) (1)
The European IPF Registry: Addressing challenges and characteristics of patients with Idiopathic Pulmonary Fibrosis (2018) (1)
MUC5B rs35705950 minor allele associates with older age and better survival in idiopathic pulmonary fibrosis (2022) (1)
Association of mUC5B rs35705950 minor allele with age and survival in European patients with Idiopathic Pulmonary Fibrosis (2022) (1)
Evaluation in a severe asthma expert center improves asthma outcomes. (2018) (1)
Progressive fibrosis is common in patients with Sjögren’s syndrome and Interstitial lung disease (2021) (1)
Clinical characteristics of patients with unclassifiable interstitial lung disease (2015) (1)
Cytokines in pulmonary emphysema: can results in mice be translated to humans? (2008) (1)
[New classification of idiopathic interstitial pneumonias. The king is dead. Long live the king!]. (2004) (1)
PRRX1 a pro-fibrotic mesenchymal transcription factor modulated by remodeled microenvironment in IPF (2018) (1)
Involvement of the Hedgehog signalling pathway in idiopathic pulmonary fibrosis (2011) (1)
Pirfenidone and N-acetylcysteine (NAC) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF): Exploratory Efficacy Results From the PANORAMA Study (2015) (1)
[Idiopathic interstitial pneumonias in 2016]. (2017) (1)
Prolonged sirolimus therapy in advanced pulmonary lymphangioleiomyomatosis; a multicenter French experience (2012) (1)
Clinical outcomes after lung transplantation for fibrosis in telomerase related genes mutation carriers (2019) (1)
POS0095 DEVELOPPING A SCORE TO PREDICT PRECLINICAL INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS – A CROSS-SECTIONAL STUDY FROM THE ESPOIR COHORT (2021) (1)
Alveolar epithelial TET2 is not involved in the development of bleomycin‐induced pulmonary fibrosis (2021) (1)
[Fluffy nodular opacities of the lung after renal transplantation]. (2012) (1)
Inhibition of the sonic hedgehog pathway at the primary cilium prevents the effect of TGF-beta 1 on alveolar epithelial cells (2012) (1)
LONG-TERM TREATMENT OF PATIENTS WITH GASTRIC-ULCER - SUCRALFATE VERSUS RANITIDINE VERSUS NO TREATMENT - AN INTERIM-REPORT AT THE END OF YEAR-1 OF A 3-YEAR MULTICENTER, RANDOMIZED STUDY (1994) (1)
[Organizing pneumonia]. (2010) (1)
FRI0460 Pulmonary Fibrosis in Anca-Associated Vasculitis: Clinical Characteristics and Long-Term Followup of 49 Patients (2014) (1)
[Diagnosis of interstitial lung disease]. (2004) (1)
Hepatocyte Growth Factor Production by Neutrophils Infiltrating Bronchioloalveolar Subtype Pulmonary Adenocarcinoma : Role in Tumor Progression and Death 1 (2003) (1)
Regulation of immune cells in lung fibrosis: the reign of regnase-1? (2021) (1)
Inhibition of the Arp2/3 complex represses human lung myofibroblast differentiation and attenuates bleomycin‐induced pulmonary fibrosis (2021) (1)
Periplakin: A New Antigenic Target in Idiopathic Pulmonary Fibrosis?. (2009) (1)
Efficacy and Safety of Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) by Body Mass Index (BMI) at Baseline: Subgroup Analysis of the SENSCIS Trial (2020) (1)
Chronic use of inhaled corticosteroids in patients admitted for respiratory virus infections: a 6-year prospective multicenter study (2022) (1)
Targeting the hedgehog/GLI pathway decreases bleomycin-induced lung fibrosis (2013) (1)
[Suspected severe acute respiratory syndrome (SARS). Observations on radiology]. (2003) (1)
RCT Abstract - Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomized, double-blind, placebo-controlled, phase 3 trial (2021) (1)
Relationship between body mass index (BMI) and decline in FVC in patients with IPF* (2019) (1)
Agreement Between Pulmonologists For The Diagnosis Of Interstitial Lung Disease: A Study Of 275 Pulmonologists From 54 Countries (2017) (1)
[Drug treatments for idiopathic pulmonary fibrosis]. (2005) (1)
Genetics in Idiopathic Pulmonary Fibrosis: A Clinical Perspective (2022) (1)
Association between influenza vaccination and the occurrence of acute exacerbation in idiopathic pulmonary fibrosis (2020) (1)
Reactivation of developmental pathways in idiopathic pulmonary fibrosis: FGF9 and FGF18 modulate the phenotype of control and fibrotic human lung fibroblastsin vitro (2015) (1)
Targeting the nasty nestin to shoot lung fibrosis (2022) (1)
GermlineSFTPA1mutation in familial idiopathic interstitial pneumonia and lung cancer (2016) (1)
SAT0329 IS THE RATE OF LUNG FUNCTION DECLINE THE SAME IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED ILD (SSC-ILD) WHO EXPERIENCE WEIGHT LOSS? DATA FROM THE SENSCIS TRIAL (2020) (1)
[Evidence based respiratory medicine. 6th update workshop of SPLF March 30th, 2007. Interstitial lung diseases]. (2007) (1)
Demographics and Baseline Characteristics of Patients with Idiopathic Pulmonary Fibrosis (IPF) in a Real-World Setting: Results of 847 Patients Enrolled in the Radico-ILD Cohort in France (2020) (1)
[Endoscopic lung volume reduction for emphysema]. (2019) (1)
Natural history of idiopathic pulmonary fibrosis (IPF) associated with obstructive sleep apnea (OSA) with or without continuous positive airway pressure (CPAP) (2018) (1)
Interstitial lung disease following coronavirus disease 2019 (2022) (1)
Contents Vol. 86, 2013 (2014) (1)
[The relationship between inflammation and symptoms in asthma]. (2008) (1)
Epidemiology of interstitial lung disease in systemic lupus erythematosus in France: A nation‐wide population‐based study over 10 years (2022) (1)
Molecular biomarkers in idiopathic pulmonary fibrosis and disease severity. (2013) (1)
[Pneumocystis pneumonia in a patient treated with pemetrexed for non small cell lung cancer]. (2011) (1)
FGFR4 has pro fibrotic properties in Idiopathic Pulmonary Fibrosis (2020) (1)
[Adult asthma exacerbations in questions]. (2010) (1)
Looking for somatic mutations in fibrosing interstitial lung diseases. (2021) (1)
Comparison Of Serial Lung High Resolution Computed Tomography Findings And Pulmonary Function Results In The Course Of Adult Pulmonary Langerhans Cell Histiocytosis (2011) (1)
Are Bronchioles Fueling Burning Alveoli in Lung Fibrosis? (2009) (1)
Multiple pulmonary nodules: and if it was not a cancer (2010) (1)
Response to letter entitled: Re: Immune checkpoint blockade for patients with lung cancer and idiopathic pulmonary fibrosis (2021) (1)
Otological Manifestations in Adults with Primary Ciliary Dyskinesia: A Controlled Radio-Clinical Study (2022) (1)
Complications respiratoires des médicaments cardiovasculaires (2006) (1)
Enquête sur le vécu, le parcours de soin, et les attentes des patients atteints de fibrose pulmonaire (2014) (1)
Les exacerbations de lasthme de ladulte en questions (2010) (1)
Prévalence et incidence des pneumopathies interstitielles diffuses chroniques (PIDC) en Seine-Saint-Denis (SSD) : analyse à 8 mois (2013) (1)
Pneumocystose chez un patient trait par pemetrexed pour adnocarcinome pulmonaire (2011) (1)
Atteinte bronchiolaire au cours du syndrome de Gougerot-Sjögren primitif (2008) (1)
Mécanismes physiopathologiques de la fibrose pulmonaire idiopathique (2010) (1)
Le diabète : facteur de risque pour la fibrose pulmonaire idiopathique ou association fortuite ? (2004) (1)
CVF initiale et effet du nintédanib sur la réduction du déclin de la fonction pulmonaire chez des patients atteints de FPI : résultats des études Inpulsis™ (2016) (1)
Sclérodermie et inflammation alvéolaire (1996) (1)
Deux traitements efficaces pour la fibrose pulmonaire idiopathique : une nouvelle ère commence ! (2015) (1)
Iconographies supplémentaires de l'article : Évaluation de la fonction respiratoire chez le sujet âgé (2008) (1)
Prévalence et pronostic des anticorps antipériplakine au cours de la fibrose pulmonaire idiopathique (2013) (1)
Évolution des aspects scannographiques des pneumopathies interstitielles associées aux anticorps anti-synthétases (2013) (1)
Le polymorphisme commun de MUC5B est associé à la fibrose pulmonaire idiopathique mais pas à l’atteinte interstitielle de la sclérodermie (2013) (1)
Préface de la Société de Pneumologie de Langue Française (2006) (1)
Traitement de la protéinose alvéolaire par transplantation intrapulmonaire de macrophages (2015) (1)
Atteintes pulmonaires infiltrantes révélatrices des connectivites (2006) (1)
La fluticasone : un nouveau corticode inhal Proprits pharmacologiques et efficacit clinique (1997) (1)
Rôle de la pollution atmosphérique dans l’histoire naturelle de la fibrose pulmonaire idiopathique (2016) (1)
Dépistage du trouble ventilatoire obstructif en population générale : résultats préliminaires de l’Opération Mesure du Souffle Bourges 2005 (2006) (1)
L’infliximab (Remicade®) est un traitement efficace des vascularites (2004) (1)
De la fibrogenèse à la fibrose : mécanismes physiopathologiques et présentations cliniques (2020) (1)
Bénéfice prolongé du sirolimus sur la fonction respiratoire dans la lymphangioléiomyomatose pulmonaire évoluée (2013) (1)
Elevation of serum tumor markers in patients with interstitial lung disease (2011) (0)
Anti periplakin antibodies in connective tissue-associated lung fibrosis (2013) (0)
LSC 2013 abstract - Expression patterns and putative roles of forkhead box F1 in normal lung and idiopathic pulmonary fibrosis (2013) (0)
[3rd French day of idiopathic pulmonary fibrosis. September 19, 2014]. (2015) (0)
Concomitant medications and efficacy of nintedanib in patients with IPF (2017) (0)
Impact of weight loss on outcomes in patients with progressive fibrosing interstitial lung diseases (ILDs) (2022) (0)
Coagulation factor IX deficiency does not afford protection from pulmonary fibrosis in the experimental murine bleomycin model (2012) (0)
Upregulation of Retinoic Acid-Related Orphan Receptor-alpha (RORa) in IPF; a promising therapeutic target (2018) (0)
No Impact of Tidal Volume on Disease Progression and Mortality in IPF Patients Recruited into the European IPF Registry (EURIPFREG) (2020) (0)
Characteristics and management of patients with idiopathic pulmonary fibrosis treated with pirfenidone capsule or tablet formulation (2020) (0)
Cohorte de patients traités par nintédanib dans le cadre de l’autorisation temporaire d’utilisation (2016) (0)
[Early gastric carcinoma: short and long term results of surgical treatment]. (1991) (0)
Partial apoptosis of epithelial cells in fibrotic lungs. (2022) (0)
Intérêt de la détection d’anti-Ro-SSA52/60 par immunodot pour le diagnostic de syndrome de Gougerot-Sjögren en l’absence d’anticorps antinucléaires (2012) (0)
Human airway trypsin-like protease: Friend or foe in idiopathic pulmonary fibrosis? (2016) (0)
Weight loss and outcomes in subjects with progressive pulmonary fibrosis: data from the INBUILD trial (2023) (0)
SP-0217: New ideas from other discipline: Successful clinical trials in IPF (idiopathic pulmonary fibrosis) (2013) (0)
Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis (2023) (0)
Alveolar Fibrocytes Are A Markers A Lung Fibrosis Severity (2012) (0)
Involvement of Circulating Fibrocytes in Pathophysiology and Prognosis of COVID-19 Pneumonia (2021) (0)
Impact of Gender on the Characteristics of Patients with Idiopathic Pulmonary Fibrosis Included in the RaDiCo-ILD Cohort (2021) (0)
[Updated indications and contraindications in 2022 for lung transplantation in France]. (2022) (0)
Axe 4: Renforcer la formation et l'information des professionnels de santé (2006) (0)
Fibroblast growth factors (FGFs) endocrines et fibrogenèse pulmonaire (2023) (0)
Morbi-mortalité après biopsie pulmonaire chirurgicale pour pneumopathie interstitielle diffuse (2020) (0)
Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part three (2017) (0)
P009 Potential role of TOLLIP (Toll interacting protein) in IPF fibroblasts (2016) (0)
Negative results > CCAAT / enhancer binding protein delta ( C / EBPδ ) deficiency does not affect bleomycin-induced pulmonary fibrosis (2018) (0)
La présence d’anticorps anti-SSA ou anti-SSB identifie un groupe particulier de patients atteints de pneumopathie infiltrante diffuse (2008) (0)
LSC 2013 abstract - Coagulation factor IX deficiency does not afford protection from bleomycin-induced pulmonary fibrosis in mice (2013) (0)
Feedback on Medical Crisis Direction at Assistance publique-Hopitaux de Paris during the COVID-19 Crisis (2020) (0)
Quelle valeur accorder à une hyperéosinophilie sanguine>1000/mm3 chez un asthmatique ? (2012) (0)
[Lung Cancer]. (2017) (0)
SP143EULAR/ERA-EDTA RECOMMENDATIONS FOR THE MANAGEMENT OF ANCA-ASSOCIATED VASCULITIS (2016) (0)
Inhaled FGF19 Therapy in Pulmonary Fibrosis (2023) (0)
No increased prevalence of autoantibodies neutralizing type I IFNs in idiopathic pulmonary fibrosis patients (2023) (0)
SFTPA mutations in interstitial lung disease (ILD) and lung cancer (2017) (0)
Effets de l'halothane et du thiopental sur la synthese de surfactant in vivo (1996) (0)
Inducible Expression of thea1-Acid Glycoprotein by Rat and Human Type II Alveolar Epithelial Cells (1998) (0)
Antifibrosic effects of sulforaphane in human lung fibroblasts from idiopathic pulmonary fibrosis (2011) (0)
Late Breaking Abstract - PRRX1 inhibition decreases fibrosis in the bleomycin-induced lung fibrosis model in mice (2018) (0)
Fibrocytes In Bronchoalveolar Lavage Fluid Are Associated With Outcome In Patients With Acute Lung Injury (2010) (0)
ACTIVATION OF SOMATOSTATIN RECEPTORS ATTENUATES PULMONARY FIBROSIS On line supplementary data (2008) (0)
[Pathophysiology of idiopathic pulmonary fibrosis]. (2010) (0)
Fibroblast Growth Facor 19, a Downregulated Factor in Idiopathic Pulmonary Fibrosis, Inhibits Mice Lung Fibrosis (2020) (0)
Higher basal tryptase, asthma and loss of consciousness in anaphylaxis are associated with biphasic reactions (2022) (0)
CT Features of Patients with Covid-19 Pneumonia at Three Months Following Infection (2021) (0)
The Autoimmune Repertoire in Idiopathic Pulmonary Fibrosis (2018) (0)
Implication of FGFR4 and its ligands in Idiopathic Pulmonary Fibrosis (2018) (0)
LSC 2014 abstract - Matriptase is an important player in fibroproliferative disorders (2014) (0)
Association between weight loss and decline in FVC in patients with IPF* (2019) (0)
Les particules diesels sont-elles nocives pour l'appareil respiratoire ? (2001) (0)
[Idiopathic pulmonary fibrosis: should corticoids still be used? Which immunosuppressive agent, for how long?]. (2004) (0)
Autoantibodies are associated with disease progression of idiopathic pulmonary fibrosis. (2023) (0)
Évolution après transplantation pulmonaire pour fibrose chez les patients porteurs d’une mutation du complexe télomérase (2019) (0)
Six-minute walk test desaturation and echocardiographic findings in IPF: Correlational observations made in the European IPF registry (eurIPFreg) (2014) (0)
[Fundamental research in Pulmonology: Progress in 2018]. (2019) (0)
Pharmaceutical compositions for parenteral administration (1970) (0)
French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2021 update. Full-length version. (2022) (0)
Human Airway Trypsin-like protease exerts potent anti-fibrotic role in vivo (2017) (0)
Discovery of Intra-Pulmonary Adipose Tissue Deposits in Pulmonary Fibrosis (2022) (0)
Maladies kystiques multiples pulmonaires (2019) (0)
Health-related quality of life in idiopathic pulmonary fibrosis (IPF): First results based on the European IPF registry (2014) (0)
Late Breaking Abstract - Prevalence and clinical significance of antinuclear antibody (ANA) in IPF: analysis from ESTAIR study (2018) (0)
Interstitial lung disease associated with systemic lupus erythematosus : a monocentric study of 23 cases (2021) (0)
Auto-anticorps neutralisant les interférons de type I et fibrose pulmonaire idiopathique (2023) (0)
Preliminary evaluation of Tenascin-C (TN-C) expression using 99mTc-aptamer scintigraphy in healthy volunteers and cancer patients (2007) (0)
Partial apoptosis of epithelial cells in Idiopathic Pulmonary Fibrosis(IPF). (2022) (0)
Intra-parenchymal adipose tissue has antifibrotic properties in pulmonary fibrosis (2023) (0)
Subcellular localisation of Nrf 2 / Keap 1 and Bach 1 in alveolar macrophages (2008) (0)
TIF1? has a protective role in pulmonary fibrosis (2018) (0)
Heme Oygenase-1 Expression Is Induced in Lung Macrophages from Smokers with Primary Spontaneous Pneumothorax: Roles of HIF-1α and Nrf2. (2009) (0)
Fibrotic-Like CT Alterations in COVID-19: Distinct Patterns of Temporal Evolution (2022) (0)
Baseline Lung Function Had No Effect on Long-Term Reduction in FVC Decline With Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (IPF) (2017) (0)
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in lung fibroblast response to TGF-β and pulmonary fibrogenesis (2017) (0)
Immune checkpoint inhibitors for patients with lung cancer and IPF: Specific clinical trials needed. (2021) (0)
[Respiratory research conference 2009]. (2010) (0)
High Prevalence and impact of lung cancer in Surfactant related gene mutation carriers (2022) (0)
[Lung transplantation for fibrosing interstitial lung disease]. (2023) (0)
OP0284 Muc5b promoter variant rs35705950 is a risk factor for rheumatoid arthritis – interstitial lung disease (2018) (0)
Intérêt de la quantification absolue du débit sanguin myocardique dans la sarcoïdose cardiaque par la TEP au 82-Rubidium (2015) (0)
Pulmonary involvement in systemic lupus erythematosus, Sjögren syndrome and mixed connective tissue disease (2019) (0)
Lung cancer in pulmonary fibrosis: no room for nihilism! (2022) (0)
Involvement of FGFR4 in Pulmonary Fibrosis Pathophysiology (0)
Arteriography and portal transhepatic catheterization in preoperative localization of four cases of gastrinoma. (1977) (0)
Long-term nintedanib treatment in idiopathic pulmonary fibrosis (IPF): final data from INPULSIS-ON (2019) (0)
Organized Lymphoid Structure in Idiopathic Immune Cells Form a Novel Type of Cutting Edge: Nonproliferating Mature (2006) (0)
FGF19, a potential innovative target in Idiopathic Pulmonary Fibrosis? (2019) (0)
Lineage tracing of cells expressing the mesenchymal profibrotic transcription factor Prrx1 in the normal and fibrotic lung (2022) (0)
Targeting the DNM3OS / miR-199a~214 cluster for the treatment of fibroproliferative diseases (2018) (0)
Analysis of Effectiveness of Pirfenidone in Subgroups of Idiopathic Pulmonary Fibrosis Based on Real World Data from European IPF Registry (2019) (0)
Efficacité et tolérance de la pirfénidone chez les patients porteurs d’une mutation du complexe télomérase (2017) (0)
Functional and Phenotypical Characteristics of Alveolar Fibroblasts Isolated during Acute Lung Injury. (2009) (0)
Origins of Pathological Myofibroblasts in Lung Fibrosis: Insights from Lineage Tracing Mouse Models in the Single Cell RNA Sequencing Era. (2023) (0)
Changes in biomarkers with nintedanib and sildenafil in subjects with IPF in the INSTAGE trial: subgroup analysis by right heart dysfunction (RHD) (2020) (0)
Interleukin-8 release by endothelial colony-forming cells isolated from idiopathic pulmonary fibrosis patients might contribute to their pathogenicity (2019) (0)
Decline in Forced Vital Capacity (FVC) in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) in Consecutive 6-Month Periods of the SENSCIS Trial (2022) (0)
Safety and tolerability of N-acetylcysteine (NAC) with pirfenidone in IPF: PANORAMA (2016) (0)
Inhibition of profibrotic signaling in fibroblasts from patients with IPF by the pan-histone deacetylase-inhibitor LBH589 or the IPF drug pirfenidone (2015) (0)
ERS Lung Science Conference 2016 report (2016) (0)
Fibroblast growth factor 9 (FGF9) modulates mesothelial cells plasticity to decrease differentiation and migrationin vitro (2016) (0)
Minimally Invasive Technique for Bronchoplastic Procedure (2017) (0)
Pneumopathies interstitielles : c’est dans l’air (2021) (0)
[Fibroblast growth factor (FGF) endocrines and pulmonary fibrogenesis]. (2023) (0)
TERT/TERC mutations in a Greek cohort of suspected genetic pulmonary fibrosis patients (2018) (0)
Subacute Exacerbation of Idiopathic Pulmonary Fibrosis: Incidence, Characteristics and Outcomes (2019) (0)
Lung inflammation and immunity: report from the 12th ERS Lung Science Conference (2014) (0)
Does excluding subjects with features similar to IPF affect the results of the INBUILD trial of nintedanib? (2020) (0)
Action of insulin inhibitors on exocrine pancreatic secretion of the rat with chronic pancreatic fistula. (1976) (0)
[Chronic infiltrative lung disease with honeycomb pattern: observation]. (2006) (0)
Lineage Tracing of Cells Expressing the Mesenchymal Profibrotic Transcription Factor Prrx1 (Paired Related Homeobox Protein 1) in Normal and Fibrotic Lung (2022) (0)
LSC Abstract – Human airway trypsin-like protease: Friend or foe in idiopathic pulmonary fibrosis? (2016) (0)
Immunologie et infection pulmonaire (1999) (0)
AB1138 BONE SARCOIDOSIS: USEFULNESS OF 18F-FDG PET/CT (2019) (0)
NKX2.1mutation revealed by a lymphoid interstitial pneumonia in an adult with rheumatoid arthritis (2023) (0)
Toll-like receptor (TLR4) in idiopathic lung fibrosis (IPF) (2015) (0)
Computed tomography assessment of peripheral traction bronchiolectasis: impact of minimal intensity projection (2020) (0)
Pneumopathies interstitielles (2018) (0)
Phenotyping asthma : a clue for treatments ? (2011) (0)
Nonlinear microscopy of collagen fibers (2007) (0)
Lung disease caused by non-null ABCA3 mutations: long-term follow-up (2018) (0)
Changes in biomarkers with nintedanib plus sildenafil in subjects with IPF by presence of emphysema in the INSTAGE trial (2020) (0)
1: Atteintes pulmonaires dans la sarcoïdose: Ce qu'il faut savoir (2010) (0)
THU0338 Cystic Lung Disease in Sjögren's Syndrome: An Observational Study (2016) (0)
[Rationale for the use of corticoids in lung diseases]. (1998) (0)
[Pneumology research within the INSERM: for how long?]. (2003) (0)
TRIM33 regulates TGF-ß1 secretion and Epithelial-Mesenchymal Transition in pulmonary fibrosis (2019) (0)
SRC-mediated and TKS5-enabled podosome formation is an inherent property of IPF fibroblasts, promoting ECM invasion and pulmonary fibrosis (2023) (0)
Sucralfate, ranitidine and no treatment in gastric ulcer management--a multicenter, prospective, randomized, 24-month follow-up with a study of risk factors of relapse. GISU (Interdisciplinary Group for Ulcer Study). (1992) (0)
role of nitric oxide synthases in elastase-induced emphysema : 506 (2010) (0)
La dégradation de la fonction respiratoire dans les 12 premiers mois après le diagnostic est un élément pronostique majeur dans la fibrose pulmonaire idiopathique (2004) (0)
[Telomeres and lung]. (2022) (0)
Functional assessment of newly identified SFTPA1 and SFTPA2 mutations in patients with idiopathic interstitial pneumonia (IIP) and lung cancer (2018) (0)
Spatial distribution and quantitative analysis of extracellular matrix remodelling in lung fibrosis using multiphoton microscopy (2006) (0)
by epithelial and endothelial cells. Internalization of Aspergillus fumigatus conidia (2013) (0)
Rôle potentiel de human airway trypsin-like protease dans la fibrose pulmonaire idiopathique (2015) (0)
L’etanercept (Enbrel®) n’est pas un traitement efficace de la sarcoïdose (2004) (0)
Non-pulmonary comorbidities in idiopathic pulmonary fibrosis (2015) (0)
FGF-9 overexpression prevents pleural fibrosis induced by intra-pleural adenovirus injection in mice (2015) (0)
Type II transmembrane serine protease matriptase is a mediator of pulmonary fibrosis (2013) (0)
3 D IMAGING AND SCORING OF COLLAGENOUS FIBROSIS USING SECOND HARMONIC MICROSCOPY (2007) (0)
[Scleroderma and alveolar inflammation]. (1996) (0)
[Diagnostic uncertainty, working diagnosis and progress of recommendations for pulmonary fibrosis]. (2018) (0)
POS0064 EPIDEMIOLOGY OF INTERSTITIAL LUNG DISEASE IN SYSTEMIC LUPUS ERYTHEMATOSUS IN FRANCE: A NATION-WIDE POPULATION-BASED STUDY OVER 10 YEARS (2022) (0)
[Idiopathic pulmonary fibrosis: Update of French practical guidelines]. (2022) (0)
[Research is the future of pulmonary medicine. Welcome to the "Journées de recherche respiratoire" (J2R)!]. (2005) (0)
Purpose of the Conference (2012) (0)
OP0099 EPIDEMIOLOGY AND MORTALITY OF RA-ASSOCIATED INTERSTITIAL LUNG DISEASE: DATA FROM A FRENCH ADMINISTRATIVE HEALTHCARE DATABASE (2021) (0)
LATE-BREAKING ABSTRACT: Safety and tolerability of N-acetylcysteine (NAC) with pirfenidone in idiopathic pulmonary fibrosis (IPF): PANORAMA (2015) (0)
[Evidence based pneumology: 3rd update workshop to the SPLF. Idiopathic diffuse interstitial pneumopathies]. (2004) (0)
Lung 18F-FDG uptake correlates with lung function alteration in patients with IPF (2014) (0)
LSC Abstract – Medium-throughput RNA interference assays identify phenotype regulators of lung mesenchymal cells based on proteomics profiling (2016) (0)
[Lung opacities]. (2011) (0)
Clinical Impact of Surgical Lung Biopsy for Interstitial Lung Disease in a Reference Center. (2021) (0)
LSC Abstract – Toll-like receptor 4 (TLR4) in idiopathic pulmonary fibrosis (IPF) (2015) (0)
New insights into methylome alterations and consequences during myofibroblastic differentiation in pulmonary fibrosis (2022) (0)
021 L’acide tout-trans rétinoïque n’induit pas l’expression de l’élastine par les fibroblastes de poumon emphysémateux humain : rôle de CRABP2 (2007) (0)
Un nouveau rôle potentiel de Human Airway Trypsin-like protease dans la fibrose pulmonaire (2014) (0)
Effets anti-inflammatoires de la théophylline dans le traitement de l'asthme (2001) (0)
Épidémiologie de la pneumopathie interstitielle dans le lupus érythémateux systémique en France: une étude à l’échelle nationale sur 10 ans (2021) (0)
Evaluation of Efficacy and Safety of Rituximab in Hypersensitivity Pneumonitis (HP) Patients: A Retrospective Observational Study (2020) (0)
2022 Update of indications and contraindications for lung transplantation in France. (2022) (0)
Relation entre inflammation et symptômes dans l’asthme.Rev Mal Respir, 28 (2008), pp. 933-951 (2008) (0)
Pneumopathie infiltrante avec aspect en rayon de miel (2006) (0)
Axe 2: Soutenir la recherche (2006) (0)
029 - Étude de l'expression pulmonaire de l'hème-oxygenase-1 dans les pneumothorax idiopathiques (2006) (0)
[Intrathoracic sarcoidosis associated with tuberculous spondylodiscitis. 2 cases]. (1990) (0)
Iconographies supplémentaires de l'article : Manifestations respiratoires au cours du syndrome de Gougerot-Sjögren (2008) (0)
La petite protéine de choc thermique αB-crystallin a un rôle clé dans la fibrogenèse pulmonaire par son action sur la SMAD4 (2014) (0)
J2R 2007 : Troisième édition ! (2007) (0)
La recherche est l'avenir de la pneumologie : place aux Journées de recherche respiratoire (J2R) ! (2005) (0)
Étude du lignage des cellules exprimant le facteur de transcription mésenchymateux profibrosant Prrx1 (Paired Related Homeobox protein 1) dans le poumon normal et de fibrose chez la souris (2021) (0)
Les bêta-2 mimétiques sont ils dangereux ? Campons le décor de la controverse (2007) (0)
Facteurs de risque de mortalité des pneumopathies interstitielles diffuses associées à la polyarthrite rhumatoïde (2022) (0)
Axe 5: Améliorer l'accès aux soins et la qualité de la prise en charge des malades (2006) (0)
Maladie kystique pulmonaire dans le syndrome de Gougerot-Sjögren : étude observationnelle (2018) (0)
7 Défaut de sécrétion de keratinocyte growth factor par les fibroblastes pulmonaires de fibrose (2004) (0)
Iconographies supplémentaires de l'article : Maladies kystiques multiples pulmonaires (2019) (0)
Exemples de partenariats réussis d'une cohorte de maladie rare (2022) (0)
Axe 6: Développer l'information, le soutien aux malades en partenariat avec les associations de patients (2006) (0)
460 Efficacité du sirolimus sur les atteintes pulmonaires et extrapulmonaires de la lymphangioleïomyomatose (LAM) (2007) (0)
Pneumopathie interstitielle diffuse associée à la polyarthrite rhumatoïde : étude descriptive de 189 patients provenant de la cohorte française TRANSLATE (2016) (0)
Une spondyloarthrite qui s’aggrave sous biothérapie : attention au diagnostic caché (2019) (0)
Intérêt pronostique du TEP au 18F-FDG dans la fibrose pulmonaire idiopathique (2015) (0)
Distribution spatiale et analyse quantitative du remodelage de la matrice extracellulaire dans la fibrose pulmonaire par microscopie multiphoton (2006) (0)
Prévalence de mutations identifiées dans les suspicions de formes génétiques de fibroses (2015) (0)
Épidémiologie de la pneumopathie interstitielle dans le lupus érythémateux systémique en France : une étude à l’échelle nationale sur 10 ans (2022) (0)
Fibrose pulmonaire idiopathique au sein de la cohorte RaDiCo-PID (2020) (0)
An expert statment on clinical considerations before treating NTM lung infection (2020) (0)
L’hypertension artérielle pulmonaire est associée à un risque de mortalité sur liste de transplantation pulmonaire chez les patients atteints de sarcoïdose (2004) (0)
Transplantation pulmonaire pour pneumopathie interstitielle diffuse fibrosante (2023) (0)
Pneumopathie à SARS-CoV-2: évolution fonctionnelle à 3 mois et corrélation avec les anomalies radiologiques (étude post Covid M3) (2021) (0)
Les fibrocytes circulants sont associés au pronostic dans la pneumopathie sévère à SARS-CoV-2 (2021) (0)
Biologie pulmonaire: Lung biology (2014) (0)
Inhibitory role of retinoic acid-related orphan receptor alpha RORa in human lung fibroblast activation. (2022) (0)
Reflux gastro-œsophagien et maladies respiratoires (2000) (0)
Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in polymyalgia rheumatica: an observational study. (2022) (0)
Neutrophils Are a Source of HGF in the Lung (2007) (0)
Les pneumopathies interstitielles diffuses du syndrome de Gougerot-Sjögren (2022) (0)
065 Les fibroblastes pulmonaires peuvent-ils moduler la maturation des cellules dendritiques in vitro ? (2007) (0)
Autoévaluations de l'article : Fibrose pulmonaire idiopathique (2009) (0)
Complications hématologiques sévères après transplantation pulmonaire chez les patients présentant une mutation du complexe de la télomérase (2013) (0)
011 SOM-230, un nouvel analogue de la somatostatine, inhibe le développement de la fibrose pulmonaire induite par la bléomycïne chez la souris (2005) (0)
Le foetus, la nicotine et les patchs (2005) (0)
IMPAIRMENT OF LUNG DIFFUSE FUNCTION IN PATIENTS WITH PULMONARY LYMPHANGIOMYOMATOSIS (LAM) (2018) (0)
Intérêt de la 18F-FDG-TEP/TDM pour le diagnostic de la pseudo-polyarthrite rhizomélique (2022) (0)
47 - Traitement des infections respiratoires basses bactériennes (2008) (0)
Effets du nintédanib chez des patients atteints de fibrose pulmonaire idiopathique et présentant des sévérités variables de toux (2022) (0)
Impact of tidal volume, GAP index and anti-fibrotic treatment on disease progression and mortality in IPF patients (2020) (0)
Présence d’une mutation de JAK2 au cours d’un asthme hyperéosinophile (2018) (0)
Traitement et pronostic des malades atteints d’un lymphome du MALT pulmonaire (2008) (0)
Performance diagnostique de la biopsie pulmonaire chirurgicale dans la prise en charge des pneumopathies interstitielles diffuses (2020) (0)
Assessing the effectiveness of pirfenidone in changing the natural course of idiopathic pulmonary fibrosis: the data from European IPF Registry (eurIPFreg) (2020) (0)
Variation phénotypique intra- et interfamiliale dans le syndrome de Birt-Hogg-Dubé : conséquences sur la prise en charge (2010) (0)
L’efficacité à long-terme du nintédanib est maintenue chez les patients atteints de fibrose pulmonaire idiopathique (FPI) quelle que soit la dose : analyse de sous-groupe de l’étude INPULSIS-ON (2018) (0)
L’évaluation rhumatologique des patients atteints de pneumopathie interstitielle diffuse améliore le diagnostic de pneumopathie interstitielle diffuse associée à une connectivite (2021) (0)
024 Défaut d’activation du pro-HGF par les fibroblastes pulmonaires au cours de la fibrose pulmonaire idiopathique (2005) (0)
Prévalence du cancer du poumon dans une cohorte de patients porteurs d’une mutation d’un gène lié au surfactant (2023) (0)
Cas clinique n° 1 (2016) (0)
Pneumopathies interstitielles diffuses associées aux mutations de Poly(A)-specific ribonuclease (PARN) : une étude de cohorte rétrospective multicentrique (2020) (0)
Modifications du protéome nucléaire dans les fibroblastes de poumon atteint de fibrose pulmonaire idiopathique, de sclérodermie, et dans les fibroblastes traités par le TGF-1 (2014) (0)
BPCO : les corticostéroïdes inhalés sont à réserver aux formes évoluées : BPCO et asthme : à reconnaître et à traiter précocement (2003) (0)
Le TGF-b1 et la PGE2 régulent l’activation du pro-HGF par les fibroblastes pulmonaires humains (2006) (0)
Potential novel targets: Protease-activated receptors in idiopathic pulmonary fibrosis (2015) (0)
Les corticoïdes oraux réduisent la toux au cours des fibroses pulmonaires idiopathiques (2004) (0)
066 La microscopie multiphoton permet l’analyse du remodelage de la matrice extracellulaire dans la fibrose pulmonaire (2006) (0)
Parathyroid Hormone-Related Protein and Lung Injury-To the Editor (2002) (0)
13 PNDV - Évaluation de la Sandostatine LP® 30 mg dans le traitement de la fibrose pulmonaire idiopathique (2005) (0)
Effet inhibiteur de l'octreotide sur les fibroblastes pulmonaires (2008) (0)
Identification de marqueurs associés à la présence d’une pneumopathie interstitielle diffuse chez les patients atteints d’une polyarthrite rhumatoïde (2016) (0)
Les J2R 2022 de retour à Reims (2023) (0)
Le taux de déclin de la fonction pulmonaire est-il le même chez les patients atteints d’une pneumopathie interstitielle diffuse associée à la sclérodermie systémique (PID-ScS) qui présentent une perte de poids ? Données de l’étude SENSCIS (2020) (0)
L'endoscopie bronchique en pratique (2001) (0)
The functional MUC5B rs35705950 promoter polymorphism is associated with IPF but not with systemic sclerosis related interstitial lung disease (2012) (0)
Fibrose pulmonaire idiopathique et autres pneumopathies interstitielles diffuses au CPLF 2013 : avancées et perspectives (2013) (0)
L’élévation du volume des voies aériennes de conduction est indépendante de la sévérité des lésions alvéolaires au cours de la FPI (2016) (0)
Nouvelles cibles thérapeutiques dans la fibrose pulmonaire (2009) (0)
Impact des facteurs démographiques sur l’étiologie des PID (2017) (0)
Télomères et poumon (2022) (0)
8.10: Evidences of cardiac sarcoidosis: comparison of SPECT and delayed-enhanced MRI (2007) (0)
Réduction de la progression de la maladie avec le nintédanib dans les études INPULSIS (2015) (0)
Efficacité du traitement des pneumopathies interstitielles diffuses de myosites (2017) (0)
Les journées de recherche respiratoire 2009 (2010) (0)
Rôle du facteur de transcription PRRX1 dans le contrôle du phénotype des fibroblastes pulmonaires : implication dans la fibrose pulmonaire idiopathique (2016) (0)
Effet du nintédanib sur le déclin de la fonction pulmonaire selon la CVF initiale dans la fibrose pulmonaire idiopathique : résultats des études INPULSIS (2015) (0)
Axe 1: Développer les connaissances épidémiologiques (2006) (0)
Données démographiques et caractéristiques au moment du diagnostic des 847 patients atteints de fibrose pulmonaire idiopathique inclus dans la cohorte Radico-PID (2020) (0)
Un score prédictif de la survenue de pneumopathie interstitielle diffuse préclinique au cours de la polyarthrite rhumatoïde (2021) (0)
Effet du nintédanib sur la progression de la pneumopathie interstitielle diffuse associée à la sclérodermie systémique (ScS-PID) au-delà de 52 semaines : données de l’étude SENSCIS (2021) (0)
Effet protecteur du FGF21 endogène et exogène dans la fibrose pulmonaire (2023) (0)
013 Les antagonistes des récepteurs 5HT2A et 5HT2B et un inhibiteur du transporteur de la sérotonine réduisent la fibrose pulmonaire induite par la bléomycine (2005) (0)
072 Caractérisation des cellules dendritiques dans la fibrose pulmonaire à la bléomycine chez la souris (2007) (0)
Intérêt de la détection d’anti-Ro-SSA52/60 par immunodot pour le diagnostic de syndrome de Gougerot-Sjögren en cas de pneumopathie interstitielle (2013) (0)
Étude d’extension en ouvert des essais Inpulsis® (Inpulsis®–ON) sur le nintédanib dans la fibrose pulmonaire idiopathique : analyse intermédiaire (2016) (0)
La sécrétion d’interkeukine-8 par les progéniteurs endothéliaux circulants isolés de patients atteints de fibrose pulmonaire idiopathique pourrait contribuer à leur pathogénicité (2019) (0)
Mortalité prédite versus observée dans les essais cliniques du nintédanib dans la fibrose pulmonaire idiopathique (FPI) (2019) (0)
Les pneumopathies interstitielles diffuses de la polyarthrite rhumatoïde sont associées à une taille plus courte des télomères et un excès de variants rares au sein de gènes impliqués dans les téloméropathies (2022) (0)
Efficacité et sécurité d’emploi du nintédanib chez des patients âgés atteints de pneumopathies interstitielles diffuses fibrosantes progressives (PID-FP) (2023) (0)
Justification de l'utilisation des corticoïdes dans les pneumopathies. (1998) (0)
Le FGF-9 inhibe la fibrose pleurale viro-induite chez la souris (2015) (0)
Épidémiologie et mortalité de la pneumopathie interstitielle diffuse associée à la polyarthrite rhumatoïde : données nationales du SNDS (2021) (0)
Défaut d'activation de l'HGF dans la fibrose pulmonaire (2008) (0)
Seconde enquête de pratique sur la prise en charge de la fibrose pulmonaire idiopathique en France (2015) (0)
9 CPP [publication électronique exclusive] Rôle de la sérotonine dans la physiopathologie de la fibrose pulmonaire (2004) (0)
L’asthme hyperéosinophile, un phénotype à part ? (2011) (0)
Rôle de la NO synthase inductible dans le modèle d’emphysème induit par l’élastase chez la souris (2008) (0)
Une nouvelle classification des pneumopathies interstitielles idiopathiques. Le roi est mort. Vive le roi (2004) (0)
Fibrose Pulmonaire Idiopathique et cancer : évaluation ex vivo du rôle oncogénique du micro environnement (2021) (0)
Ousted health care workers because of COVID-19 infection: Back to work is not an easy move (2020) (0)
Dépistage des manifestations pulmonaires des connectivites (2022) (0)
Faisabilité de la spirométrie de dépistage de la BPCO en soins primaires (2015) (0)
Cancer associated fibroblasts subtypes are associated with histological features, immune environment and prognosis in resected non small cell lung cancer (2022) (0)
Implication de FGFR4 dans la physiopathologie de la fibrose pulmonaire idiopathique (2021) (0)
Le volume et la distribution de la graisse intrathoracique sont modifiés chez les patients atteints de fibrose pulmonaire idiopathique (2013) (0)
Effets Des Agents Anesthesiques Intraveineux Sur La Synthese De Surfactant Et Le Metabolisme Glycolytique Des Pneumocytes II De Rat En Culture Primaire (1995) (0)
Changement d’anti-fibrosant pour une progression de la fibrose pulmonaire idiopathique : une stratégie efficace ? (2021) (0)
208 Hyperfixation pulmonaire de l’octréotide au cours de la fibrose pulmonaire (2004) (0)
Adipocytes, adipokines et altérations métaboliques dans la fibrose pulmonaire (2023) (0)
Approche thérapeutique des pneumopathies interstitielles diffuses liées aux connectivites (2016) (0)
Granulome à corps étranger sur produit de comblement induit par l’omaluzimab (2011) (0)
Récupération respiratoire à distance d’une pneumonie sévère à SARS-CoV-2 (COVID-19) : résultats préliminaires de l’étude de cohorte multicentrique prospective RE2COVERI (2021) (0)
Fibrose pulmonaire idiopathique : actualisation des recommandations pratiques (2022) (0)
Fibroblastes et fibrogenèse pulmonaire. (2014) (0)
BOEHRINGER INGELHEIM - Fibroses pulmonaires : maladies pulmonaires ou maladies systémiques ? (2020) (0)
Effets du rituximab dans la liprotéinose alvéolaire auto-immune (2016) (0)
Iconographies supplémentaires de l'article : Actualités dans la prise en charge de la fibrose pulmonaire idiopathique (2013) (0)
The role of TLF4 in IPF (2014) (0)
La désaturation en oxygène lors du test de marche de 6 minutes est un facteur de gravité dans les fibroses pulmonaires idiopathiques (2004) (0)
Les avancées de la recherche fondamentale de la pneumologie en 2018… (2019) (0)
Physiopathologie de la réparation alvéolaire (2010) (0)
Low income and progression free survival in idiopathic pulmonary fibrosis: An association to uncover (2020) (0)
Matriptase triggers pleiotropic functional responses in normal human lung fibroblasts (NHLF): Potential relevance in pathophysiology (2014) (0)
Association rituximab et mycophenolate mofetil chez les patients avec une pneumopathie interstitielle non spécifique : essai contrôlé randomisé en double aveugle, contre mycophenolate mofetil et placebo (Ever-Ild) (2022) (0)
Maladie de Crohn et leucémie. (1989) (0)
Effet du lavage broncho-alvéolaire sur la migration des fibroblastes pulmonaires humains dans les agressions alvéolaires aiguës : rôle du PDGF (2008) (0)
Activation du proHGF dans le LBA au cours de la fibrose pulmonaire idiopathique (2012) (0)
Rôle dans la progression tumorale de l'HGF produit par les neutrophiles au cours des adénocarcinomes pulmonaires primitifs de type bronchioloalvéolaire (2008) (0)
8 Défaut de sécrétion d’hepatocyte growth factor (HGF) et de keratinocyte growth factor (KGF) par les fibroblastes pulmonaires d’emphysème (2004) (0)
Excès de variants rares délétères au sein de gènes appartenant à la voir JAK-STAT chez des patients atteints de pneumopathie interstitielle diffuse associée à la polyarthrite rhumatoïde (2022) (0)
020 Le Keratinocyte Growth Factor prévient l’emphysème induit par l’élastase chez la souris (2006) (0)
Le FGF9 contrôle le phénotype des fibroblastes pulmonaires humains au cours de la fibrose pulmonaire idiopathique (2015) (0)
Telomere-Related Gene mutations in a Greek cohort of suspected monogenic pulmonary fibrosis patients (2020) (0)
Autoévaluations de l'article : Lipoprotéinose alvéolaire pulmonaire (2017) (0)
Tout est dans toux (2008) (0)
Arbres décisionnels de l'article : Diagnostic des pneumopathies infiltrantes diffuses chroniques (2015) (0)
Exhalative markers FeNO, PGE2 and 8-isoprostane as diagnostic and prognostic biomarkers in interstitial lung diseases (2019) (0)
Rôle de la vaccination antigrippale sur le risque d’exacerbation aiguë dans la fibrose pulmonaire idiopathique (2021) (0)
Une cause rarissime de douleur thoracique : nécrose de la graisse paracardiaque (2011) (0)
Efficacité et tolérance des traitements anti-fibrosants chez les patients porteurs d’une mutation du complexe telomèrase (2019) (0)
Clinical and functional characteristics of patients with unclassifiable interstitial lung diseases (uILD) from eurIPFreg (2020) (0)
062 Activation du pro-HGF au cours de la fibrose pulmonaire induite par la bléomycine chez la souris (2007) (0)
Complications pulmonaires de la radiothérapie (2004) (0)
Actualités dans la prise en charge de la fibrose pulmonaire idiopathique (2013) (0)
Transplantation pulmonaire en France : actualisation des indications et contre-indications en 2022 (2022) (0)
Traitement des bronchiolites (2009) (0)
Évaluation de deux stratégies de switch de biothérapie après réponse incomplète à un anti-IL5/IL5R dans l’asthme sévère (2022) (0)
Efficacité et tolérance du nintédanib chez des patients atteints de pneumopathie interstitielle diffuse associée à la sclérodermie systémique (SSc-PID) en fonction de l’indice de masse corporelle (IMC) à l’inclusion : analyse en sous-groupes de l’étude SENSCIS (2021) (0)
Le TLG mesuré par le TEP scanner est un facteur prédictif indépendant de survie sans progression dans la FPI (2017) (0)
Cas clinique n° 1 : Dyspnée avec trouble ventilatoire obstructif au cours d’un syndrome de Gougerot-Sjögren (2016) (0)
Glucocorticoides associés à une faible dose d’anti-IL1 (Anakinra) pour les COVID-19 sévères hors réanimation une étude de cohorte (2021) (0)
Le doute persiste concernant l’efficacité de l’interféron-gamma dans la fibrose pulmonaire (2004) (0)
3e Journée française de la fibrose pulmonaire idiopathique. 19 septembre 2014 (2015) (0)
[Lung cancer in the elderly subject]. (2007) (0)
Les fibrocytes circulants sont associés au pronostic dans la pneumopathie à SARS-CoV-2 (2022) (0)
Des opacités pulmonaires (2011) (0)
Mécanismes de la fibrose pulmonaire idiopathique (2017) (0)
Fibrose pulmonaire avec ANCA : fréquence des hémorragies intra-alvéolaires et de l'évolution vers la polyangéite microscopique (2008) (0)
Intergroupe PneumoGériatrie SPLF-SFGG placé sous l’égide de la Société de Pneumologie de Langue Française (SPLF) et de la Société Française de Gériatrie et Gérontologie (SFGG):, in: Rev Mal Respir, 26 (2009), 587 (2009) (0)
Effet protecteur du FGF21 dans la fibrose pulmonaire (2023) (0)
Maladie kystique pulmonaire associée au syndrome de Gougerot-Sjögren : étude observationnelle (2015) (0)
Le FGF9 est exprimé dans le poumon au cours de la fibrose pulmonaire idiopathique et module l’activation des fibroblastes pulmonaires (2014) (0)
Pneumopathie interstitielle idiopathique et auto-immunité muqueuse anti-cellules pariétales gastriques (2016) (0)
Expression des facteurs de croissance et de leurs récepteurs dans l'emphysème pulmonaire chez l'homme (2008) (0)
[Influence of diazoxide on the response of the rat exocrine pancreas cholecystokinin-pancreozymin]. (1976) (0)
Prévalence de la pneumopathie interstitielle diffuse associée à la polyathrite rhumatoïde dans la cohorte Espoir et intérêt du génotypage de rs35705950 (2020) (0)
Syndrome emphysème fibrose au cours de la sclérodermie systémique (2013) (0)
Fibroses pulmonaires idiopathiques : doit-on encore utiliser les corticoïdes ? Quel immunosuppresseur, combien de temps ? (2004) (0)
Impact du syndrome d’apnées obstructives du sommeil (SAOS) et de son traitement par pression positive continue (PPC) sur la progression de la fibrose pulmonaire idiopathique (FPI) (2019) (0)
Impact de la pollution atmosphérique sur la survie de la fibrose pulmonaire idiopathique selon le polymorphisme MUC5B (2023) (0)
Pneumopathies interstitielles diffuses fibrosantes associées aux vascularites à ANCA : à propos de 22 observations (2013) (0)
Is hypereosinophilic asthma a specific phenotype of asthma (2011) (0)
Iconographies supplémentaires de l'article : Fibrose pulmonaire idiopathique (2009) (0)
Association entre l’indice de masse corporelle (IMC) et le déclin de la CVF chez les patients atteints de fibrose pulmonaire idiopathique (FPI) (2020) (0)
Coccidioïdomycose : deux nouveaux cas d’importation (2012) (0)
Amikacine liposomale inhalée dans le traitement des infections pulmonaires à Mycobacterium avium complexe. Étude rétrospective multicentrique (2022) (0)
Bronchiolite au cours du syndrome de Gougerot-Sjögren: une série rétrospective de 25 patients (2019) (0)
Le FGF-9 inhibe la fibrose pleurale induite par un adénovirus chez la souris (2015) (0)
Caractéristiques et prise en charge des patients atteints de fibrose pulmonaire idiopathique traités par la pirfénidone sous forme de gélules ou de comprimés : cohorte RaDiCo-PID (2021) (0)
La prévalence des Herpes virus n’est pas augmentée dans la fibrose pulmonaire idiopathique (2020) (0)
Analyse de la littératureAnalyse de la littérature (2004) (0)
Association entre la perte de poids et le déclin de la CVF chez les patients atteints de fibrose pulmonaire idiopathique (2020) (0)
P237 - Fibrose pulmonaire rapidement évolutive et mortelle lors d’un traitement par dacarbazine puis fotémustine pour un mélanome métastatique (2005) (0)
[Intra- and interfamilial phenotype variation in Birt-Hogg-Dubé syndrome: Consequences for therapy]. (2010) (0)
Iconographies supplémentaires de l'article : Lipoprotéinose alvéolaire pulmonaire (2011) (0)
Iconography : Traitements médicamenteux de la fibrose pulmonaire idiopathique (2008) (0)
Autoévaluations de l'article : Diagnostic des pneumopathies infiltrantes diffuses chroniques (2015) (0)
Intérêt prédictif du taux de fibrocytes intra-alvéolaires dans l’évolution en réanimation des patients intubés présentant une agression alvéolaire aiguë (2011) (0)
L'asthme : parce que chaque patient est unique : Comment optimiser la prise en charge en MG (2008) (0)
Les inégalités de revenus influencent la survie sans progression dans la fibrose pulmonaire idiopathique (2020) (0)
Recommandations d’experts pour la prise de décision de traiter une infection à mycobactérie non tuberculeuse (2022) (0)
Erratum à « Recommandations pratiques pour le diagnostic et la prise en charge de la fibrose pulmonaire idiopathique » [Rev. Mal. Respir. 30 (10) 879–902] (2014) (0)
079 Caractérisation des cellules dendritiques dans la fibrose pulmonaire idiopathique (2006) (0)
Pollution atmosphérique et environnementale et pathologie respiratoire (2006) (0)
Iconographies supplémentaires de l'article : Diagnostic des pneumopathies infiltrantes diffuses chroniques (2015) (0)
Effets du nintédanib sur le déclin de la fonction pulmonaire selon la CVF initiale : résultats des études INPULSIS™ (2015) (0)
Fond génétique partagé entre la pneumopathie interstitielle diffuse associée à la polyarthrite rhumatoïde et la fibrose pulmonaire idiopathique (2016) (0)
Impact du caractère familial et/ou de l’existence d’une mutation des gènes associés aux télomères chez les patients ayant une fibro-élastose pleuroparenchymateuse (2023) (0)
Implication de la matriptase dans la fibrose pulmonaire idiopathique (2015) (0)
Maladie de Castleman médiastinale : mise au point (2013) (0)
Les explorations fonctionnelles respiratoires en pratique (2001) (0)
Une plongeuse qui fait des bulles (2008) (0)
Corticoïdes et bronchopneumopathies chroniques obstructives : Bronchopneumopathies chroniques obstructives (2000) (0)
Detrimental role for matrix metalloprotease-1 in the pathogenesis of pulmonary fibrosis (2017) (0)
Pneumopathie interstitielle du syndrome des anti-synthétases : intérêt du rituximab ? (2015) (0)
Effet du nintédanib sur le déclin de la CVF chez les patients répartis en fonction de critères scannographiques de diagnostic : résultats des essais Inpulsis® dans la fibrose pulmonaire idiopathique (2016) (0)
Rheumatoid arthritis and idiopathic pulmonary fibrosis: a bidirectional Mendelian randomisation study (2022) (0)
Les avancées de la recherche fondamentale - Quelle est l’origine des fibroblastes dans les fibroses pulmonaires ? La « souris verte » apporte un brin de réponse (2004) (0)
Physiopathologie de la fibrose pulmonaire idiopathique (FPI) (2011) (0)
Atteintes interstitielles pulmonaires au cours du lupus érythémateux systémique. Étude rétrospective multicentrique de 89 cas (2022) (0)
Prévalence des anticorps anti-périplakine dans les fibroses pulmonaires associées aux connectivites (2014) (0)
Les propriétés non apoptotiques et profibrosantes de la protéine BAX nucléaire dans la fibrose pulmonaire idiopathique (2014) (0)
La fibroélastose bronchocentrique : une nouvelle entité ? (2015) (0)
Différences entre les genres dans la fibrose pulmonaire idiopathique : les hommes et les femmes sont-ils égaux ? (2021) (0)
Des nodules pulmonaires flous persistant après transplantation rénale (2012) (0)
Pneumopathies interstitielles associées au lupus érythémateux disséminé : étude multicentrique de 44 cas (2022) (0)
Le pasireotide (SOM230) inhibe la synthèse de collagène 1 par les fibroblastes pulmonaires humains in vitro (2008) (0)
29 – Atteintes pleuro-pulmonaires associées au lupus érythémateux (2013) (0)
Interstitial lung diseases associated with mutations of poly(A)-specific ribonuclease: a multicentric retrospective cohort study (2020) (0)
Atteintes bronchiolaires de la polyarthrite rhumatoïde et du syndrome de Gougerot-Sjögren (2018) (0)
Corticoïdes et bronchopneumopathies chroniques obstructives (2000) (0)
Revue générale Relation entre inflammation et symptômes dans l ’ asthme (2008) (0)
028 Diminution de l’expression pulmonaire de l’hème-oxygenase 1 dans l’emphysème sévère (2006) (0)
Rate of FEV1 decline in lymphangioleiomyomatosis associated with tuberous sclerosis complex (2012) (0)
LSC Abstract – Activation of FGF9 and 18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts (2016) (0)
Étude observationnelle FAS chez des patients atteints de fibrose pulmonaire idiopathique traités par pirfénidone en vie réelle en France (2019) (0)
Discovery of intra-parenchymal adipose tissue as a component of tissue remodeling in pulmonary fibrosis (2022) (0)
Self-reported sleep quality in IPF (2014) (0)
Rituximab therapy for interstitial lung disease in patients with antisynthetase syndrome (2013) (0)
Nonlinear microscopy using Second Harmonic Generation from myosin filaments and fibrillar collagens (2006) (0)
[Two new drugs for the treatment of idiopathic lung fibrosis: A new therapeutic era!]. (2015) (0)
Clinical and Functional Characteristics of Patients with Unclassifiable Interstitial Lung Diseases (UILD). Data from the European IPF Registry (EURIPFREG) (2020) (0)
[Focus on mediastinal Castleman disease]. (2013) (0)
The role of TLR4 in IPF (2014) (0)
Supplementary Material for: Investigation of Lung Involvement in Connective Tissue Disorders (2016) (0)
Imbalance of circulating endothelial cells and progenitors in idiopathic pulmonary fibrosis (2012) (0)
Telomere syndrome and the lung (2019) (0)
THU0106 Identification of Markers Associated with The Occurrence of Interstitial Lung Disease in Rheumatoid Arthritis Patients (2016) (0)
[Fibroblasts and lung fibrosis]. (2014) (0)
Implication du récepteur FGFR4 et de ses ligands dans la Fibrose Pulmonaire Idiopathique (2019) (0)
Fibrocytes are detected in bronchoalveolar lavage (BAL) fluid in idiopathic pulmonary fibrosis (IPF) (2011) (0)
POS1397 USEFULNESS OF 18F-FDG PET/CT FOR POLYMYALGIA RHEUMATICA DIAGNOSIS (2022) (0)
[Function of pneumocytes II]. (1995) (0)
Ectopic subpleural fat deposition in idiopathic pulmonary fibrosis correlates with radiographic extension of fibrosis (2013) (0)
[Pleuropulmonary manifestations of rheumatoid arthritis]. (1996) (0)
[Invasive pulmonary aspergillosis in human immunodeficiency virus infection. Diagnostic value of bronchoalveolar lavage]. (1994) (0)
Sftpa1 Mutation In Familial Idiopathic Interstitial Pneumonia And Lung ă Cancer (2016) (0)
Incidence, caractéristiques et valeur pronostique de l’exacerbation subaiguë dans la fibrose pulmonaire idiopathique (2020) (0)
Axe 3: Prévenir la BPCO dans la population générale (2006) (0)
Pneumopathie interstitielle diffuse isolée inaugurale et anticorps anti-JO-1 (2008) (0)
No evidence for a pathogen associated with pulmonary MALT lymphoma: a metagenomics investigation (2021) (0)
What is new in the approach to pulmonary fibrosis ? (2011) (0)
LSC - 2019 - TRIM33 regulates TGF-ß1 secretion and Epithelial-Mesenchymal Transition in pulmonary fibrosis (2019) (0)
Hétérogénéité de l’atteinte respiratoire associée aux mutations de NK2 homeobox 1 (2017) (0)
099 Étude de l’implication d’EMMPRIN et de c-Jun N-terminal Kinase (JNK) dans la production de MMPs par des fibroblastes (2006) (0)
La pneumonie organisée : une manifestation inaugurale possible des connectivites, dont le syndrome de Gougerot-Sjögren (2010) (0)
No association between Human herpes virus, Herpes virus Saimiri and idiopathic pulmonary fibrosis (2019) (0)
Fibroblast growth factor 9 (FGF9) modulates the phenotype of control and fibrotic human lung fibroblasts in vitro (2014) (0)
Involvement of FGF21 in Pulmonary Fibrosis (2022) (0)
A Phase 2, double-blind, placebo-controlled study of N–acetylcysteine in combination with pirfenidone in patients with idiopathic pulmonary fibrosis (2014) (0)
human polymorphonuclear neutrophils Presence of a mobilizable intracellular pool of hepatocyte growth factor in (2013) (0)
Whatever ‘smells’ like COVID-19 is not always COVID-19 (2022) (0)
Imbalance between circulating endothelial cells and endothelial progenitors in idiopathic pulmonary fibrosis (2011) (0)
The FLORA study: presenting a novel IPF trial design. (2018) (0)
Anti-parietal cell autoimmunity in IPF patients (2016) (0)
Migratory b bronchiolitis o obliterans o organizing p pneumonia a after unilateral rradiation ttherapy ffor b breast c carcinoma (1995) (0)
Pulmonary expression of alternatively spliced tissue factor as a potential prognostic marker in idiopathic pulmonary fibrosis (2015) (0)
Association between influenza vaccination and the occurrence of acute exacerbation inidiopathic pulmonary fibrosis (2021) (0)
[Adipocytes, adipokines and metabolic alterations in pulmonary fibrosis]. (2023) (0)
Prognosis of Invasive Mechanical Ventilation in Patients with Idiopathic Fibrotic Lung Diseases. (2009) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Bruno Crestani?

Bruno Crestani is affiliated with the following schools:

Bruno Crestani's Academic­Influence.com Rankings

Bruno Crestani's Degrees

Similar Degrees You Can Earn

Why Is Bruno Crestani Influential?

Bruno Crestani's Published Works

Published Works

What Schools Are Affiliated With Bruno Crestani?

Bruno Crestani's AcademicInfluence.com Rankings